# EDGAR Filing Document

**Accession Number:** 0001166388
**File Stem:** 0001166388-25-000098
**Filing Date:** 2025-6
**Character Count:** 233277
**Document Hash:** 6c87b2607e84f8f6137b0e8339eb30c1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001166388-25-000098.hdr.sgml**: 20250604

**ACCESSION NUMBER**: 0001166388-25-000098

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 107

**CONFORMED PERIOD OF REPORT**: 20250430

**FILED AS OF DATE**: 20250604

**DATE AS OF CHANGE**: 20250604

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** VERINT SYSTEMS INC
- **CENTRAL INDEX KEY:** 0001166388
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 113200514
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0131

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34807
- **FILM NUMBER:** 251023804

**BUSINESS ADDRESS:**
- **STREET 1:** 225 BROADHOLLOW ROAD
- **CITY:** MELVILLE
- **STATE:** NY
- **ZIP:** 11747
- **BUSINESS PHONE:** 6319629600

**MAIL ADDRESS:**
- **STREET 1:** 225 BROADHOLLOW ROAD
- **CITY:** MELVILLE
- **STATE:** NY
- **ZIP:** 11747

?xml version='1.0' encoding='ASCII'? vrnt-20250430

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549** 

**FORM 10-Q** 

(Mark One)

---

| | |
|:---|:---|
| ☑ | **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** |

---

**For the quarterly period ended April 30, 2025**

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>.**

**Commission File No. 001-34807**

![verintlogoa08.jpg](vrnt-20250430_g1.jpg)

**Verint Systems Inc.** 

(Exact Name of Registrant as Specified in its Charter)

---

| | | |
|:---|:---|:---|
| Delaware | Delaware | 11-3200514 |
| (State or Other Jurisdiction of Incorporation or<br>Organization) | (State or Other Jurisdiction of Incorporation or<br>Organization) | (I.R.S. Employer Identification No.) |
| 225 Broadhollow Road | 225 Broadhollow Road |  |
| Melville, | New York | 11747 |
| (Address of Principal Executive Offices) | (Address of Principal Executive Offices) | (Zip Code) |

---

 <u>(631)</u> <u>962-9600</u> <br> (Registrant's Telephone Number, Including Area Code)

---

| | | |
|:---|:---|:---|
| **Securities registered pursuant to Section 12(b) of the Act:** | **Securities registered pursuant to Section 12(b) of the Act:** | **Securities registered pursuant to Section 12(b) of the Act:** |
| **<u>Title of each class</u>** | **<u>Trading Symbol(s)</u>** | **<u>Name of each exchange on which registered</u>** |
|  |  | **The NASDAQ Stock Market, LLC** |
| **Common Stock, $.001 par value per share** | **VRNT** | **(NASDAQ Global Select Market)** |

---

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☑ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

There were 60,160,405 shares of the registrant's common stock outstanding on May 15, 2025.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

---

| | | |
|:---|:---|:---|
| **Verint Systems Inc. and Subsidiaries** | **Verint Systems Inc. and Subsidiaries** | **Verint Systems Inc. and Subsidiaries** |
| **Index to Form 10-Q** | **Index to Form 10-Q** | **Index to Form 10-Q** |
| **As of and For the Period Ended April 30, 2025** | **As of and For the Period Ended April 30, 2025** | **As of and For the Period Ended April 30, 2025** |
| | | **Page** |
| [Cautionary Note on Forward-Looking Statements](#i8df5a199fd074a0db305e1acb96f1d88_13) | [Cautionary Note on Forward-Looking Statements](#i8df5a199fd074a0db305e1acb96f1d88_13) | [ii](#i8df5a199fd074a0db305e1acb96f1d88_13) |
| **[Part I.](#i8df5a199fd074a0db305e1acb96f1d88_16)** | **[Financial Information](#i8df5a199fd074a0db305e1acb96f1d88_16)** | **[1](#i8df5a199fd074a0db305e1acb96f1d88_16)** |
| [Item 1.](#i8df5a199fd074a0db305e1acb96f1d88_19) | [Financial Statements (Unaudited)](#i8df5a199fd074a0db305e1acb96f1d88_19) | [1](#i8df5a199fd074a0db305e1acb96f1d88_19) |
|  | [Condensed Consolidated Balance Sheets](#i8df5a199fd074a0db305e1acb96f1d88_22) | [2](#i8df5a199fd074a0db305e1acb96f1d88_22) |
|  | [Condensed Consolidated Statements of Operations](#i8df5a199fd074a0db305e1acb96f1d88_25) | [3](#i8df5a199fd074a0db305e1acb96f1d88_25) |
|  | [Condensed Consolidated Statements of Comprehensive Income](#i8df5a199fd074a0db305e1acb96f1d88_28) | [4](#i8df5a199fd074a0db305e1acb96f1d88_28) |
|  | [Condensed Consolidated Statements of Stockholders' Equity](#i8df5a199fd074a0db305e1acb96f1d88_31) | [5](#i8df5a199fd074a0db305e1acb96f1d88_31) |
|  | [Condensed Consolidated Statements of Cash Flows](#i8df5a199fd074a0db305e1acb96f1d88_34) | [6](#i8df5a199fd074a0db305e1acb96f1d88_34) |
|  | [Notes to Condensed Consolidated Financial Statements](#i8df5a199fd074a0db305e1acb96f1d88_37) | [7](#i8df5a199fd074a0db305e1acb96f1d88_37) |
| [Item 2.](#i8df5a199fd074a0db305e1acb96f1d88_94) | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#i8df5a199fd074a0db305e1acb96f1d88_94) | [33](#i8df5a199fd074a0db305e1acb96f1d88_94) |
| [Item 3.](#i8df5a199fd074a0db305e1acb96f1d88_109) | [Quantitative and Qualitative Disclosures About Market Risk](#i8df5a199fd074a0db305e1acb96f1d88_109) | [48](#i8df5a199fd074a0db305e1acb96f1d88_109) |
| [Item 4.](#i8df5a199fd074a0db305e1acb96f1d88_112) | [Controls and Procedures](#i8df5a199fd074a0db305e1acb96f1d88_112) | [49](#i8df5a199fd074a0db305e1acb96f1d88_112) |
| **[Part II.](#i8df5a199fd074a0db305e1acb96f1d88_115)** | **[Other Information](#i8df5a199fd074a0db305e1acb96f1d88_115)** | **[50](#i8df5a199fd074a0db305e1acb96f1d88_115)** |
| [Item 1.](#i8df5a199fd074a0db305e1acb96f1d88_118) | [Legal Proceedings](#i8df5a199fd074a0db305e1acb96f1d88_118) | [50](#i8df5a199fd074a0db305e1acb96f1d88_118) |
| [Item 1A.](#i8df5a199fd074a0db305e1acb96f1d88_121) | [Risk Factors](#i8df5a199fd074a0db305e1acb96f1d88_121) | [50](#i8df5a199fd074a0db305e1acb96f1d88_121) |
| [Item 2.](#i8df5a199fd074a0db305e1acb96f1d88_124) | [Unregistered Sales of Equity Securities and Use of Proceeds](#i8df5a199fd074a0db305e1acb96f1d88_124) | [50](#i8df5a199fd074a0db305e1acb96f1d88_124) |
| [Item 3.](#i8df5a199fd074a0db305e1acb96f1d88_127) | [Defaults Upon Senior Securities](#i8df5a199fd074a0db305e1acb96f1d88_127) | [51](#i8df5a199fd074a0db305e1acb96f1d88_127) |
| [Item 4.](#i8df5a199fd074a0db305e1acb96f1d88_130) | [Mine Safety Disclosures](#i8df5a199fd074a0db305e1acb96f1d88_130) | [51](#i8df5a199fd074a0db305e1acb96f1d88_130) |
| [Item 5.](#i8df5a199fd074a0db305e1acb96f1d88_133) | [Other Information](#i8df5a199fd074a0db305e1acb96f1d88_133) | [51](#i8df5a199fd074a0db305e1acb96f1d88_133) |
| [Item 6.](#i8df5a199fd074a0db305e1acb96f1d88_136) | [Exhibits](#i8df5a199fd074a0db305e1acb96f1d88_136) | [52](#i8df5a199fd074a0db305e1acb96f1d88_136) |
| **[Signature](#i8df5a199fd074a0db305e1acb96f1d88_139)** |  | **[53](#i8df5a199fd074a0db305e1acb96f1d88_139)** |

---

i

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

**Cautionary Note on Forward-Looking Statements**

This Quarterly Report on Form 10-Q contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, the provisions of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking statements include, but are not limited to, financial projections, statements of plans and objectives for future operations, statements of future economic performance, and statements of assumptions relating thereto. Forward-looking statements may appear throughout this report, including without limitation, in Part I, Item 2, "Management's Discussion and Analysis of Financial Condition and Results of Operations", and are often identified by future or conditional words such as "will", "plans", "expects", "intends", "believes", "seeks", "estimates", or "anticipates", or by variations of such words or by similar expressions. There can be no assurance that forward-looking statements will be achieved. By their very nature, forward-looking statements involve known and unknown risks, uncertainties, assumptions, and other important factors that could cause our actual results or conditions to differ materially from those expressed or implied by such forward-looking statements. Important risks, uncertainties, assumptions, and other factors that could cause our actual results or conditions to differ materially from our forward-looking statements include, among others:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• uncertainties regarding the impact of changes in macroeconomic and/or global conditions, including as a result of slowdowns, recessions, economic instability, actual or threatened tariffs or trade wars, elevated interest rates, tightening credit markets, inflation, instability in the banking sector, political unrest, armed conflicts, epidemics or pandemics, or natural disasters, as well as the resulting impact on spending by customers or partners, on our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks that our customers or partners delay, downsize, cancel, or refrain from placing orders or renewing subscriptions or contracts, or are unable to honor contractual commitments or payment obligations due to challenges or uncertainties in their budgets, headcount, liquidity, businesses, or operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with our ability to keep pace with technological advances, such as the advancement and proliferation of artificial intelligence ("AI") and evolving industry standards and challenges, including: achieving, demonstrating, and maintaining the competitive differentiation of our solution platform; adapting to changing market potential from area to area within our markets; and successfully developing, launching, executing and driving demand for new and enhanced, innovative, high-quality products and services, while simultaneously preserving our legacy businesses and migrating away from areas of commoditization;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks due to aggressive competition in all of our markets and our ability to keep pace with competitors, some of whom may be able to innovate or grow faster than us or may have greater resources than us, including in areas such as sales and marketing, brand recognition, technological innovation and development, and recruiting and retention;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with our ability to properly execute on our software as a service ("SaaS") strategy, the increased importance of new subscriptions and renewals and associated term lengths, and risk of increased variability in our period-to-period results based on the mix, terms, and timing of our transactions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• challenges associated with selling sophisticated solutions and cloud-based solutions, which may incorporate newer technologies, such as AI, whose adoption, value, and use-cases are still emerging (and may present risks of their own), including with respect to longer sales cycles, more complex sales processes and customer evaluation and approval processes, more complex contractual and information security requirements, and assisting customers in understanding and realizing the benefits of our solutions and technologies (including versus those of our competitors), as well as with developing, offering, implementing, and maintaining an enterprise-class, broad solution portfolio;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with our ability to or costs to retain, recruit, and train qualified personnel and management in regions in which we operate either physically or remotely, including in areas of emerging technology such as AI, due to competition for talent, increased labor costs, applicable regulatory requirements, or otherwise;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks relating to our ability to properly identify and execute on growth or strategic initiatives, manage investments in our business and operations, and enhance our existing operations and infrastructure, including the proper prioritization and allocation of limited financial and other resources;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks that we may be unable to maintain, expand, or enable our relationships with partners as part of our growth strategy, including partners with whom we may overlap or compete, while avoiding excessive concentration with one or more partners;

ii

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with our reliance on third-party suppliers, partners, or original equipment manufacturers ("OEMs") for certain services, products, or components, including companies that may compete with us or work with our competitors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with our significant international operations, including exposure to regions subject to political or economic instability or hostilities, fluctuations in foreign exchange rates, inflation, increased financial accounting and reporting burdens and complexities, and challenges associated with a significant portion of our cash being held overseas;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with a significant part of our business coming directly or indirectly from government contracts, and associated procurement processes and regulatory requirements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with our ability to identify suitable targets for acquisition or investment or successfully compete for, consummate, and implement mergers and acquisitions, including risks associated with valuations, legacy liabilities, reputational considerations, capital constraints, costs and expenses, maintaining profitability levels, expansion into new areas, management distraction, post-acquisition integration activities, and potential asset impairments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with complex and changing domestic and foreign regulatory environments, including, among others, with respect to data privacy, AI, cyber/information security, government contracts, anti-corruption, trade compliance, climate change or other environmental, social and governance matters, tax, and labor matters, relating to our own operations, the products and services we offer, and/or the use of our solutions by our customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with the development and use of AI, including regulatory, social, or ethical issues, as well as our ability to capitalize on and benefit from the advancement and proliferation of AI;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with the mishandling or perceived mishandling of sensitive or confidential information and data, including personally identifiable information or other information that may belong to our customers or other third parties, including in connection with our SaaS or other hosted or managed services offerings or when we are asked to perform service or support;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks that our solutions or services, or those of third-party suppliers, partners, or OEMs which we use in or with our offerings or otherwise rely on, including third-party hosting platforms, may contain defects, develop operational problems, or be subject to security vulnerabilities or lapses, including cyber-attacks, information technology system breaches, failures, or disruptions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with our reliance on third parties to provide certain cloud hosting or other cloud-based services to us or our customers, including the risk of service disruptions, data breaches, or data loss or corruption;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks that our intellectual property ("IP") rights may not be adequate to protect our business or assets or that others may make claims on our IP, claim infringement on their IP rights, or claim a violation of their license rights, including relative to free or open source components we may use;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with leverage resulting from our current debt position or our ability to incur additional debt, including with respect to liquidity considerations, covenant limitations and compliance, fluctuations in interest rates, dilution considerations (with respect to our convertible notes), and our ability to maintain our credit ratings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks that we may experience liquidity or working capital issues and risks that financing or refinancing sources may be unavailable to us on reasonable terms or at all;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with changing accounting principles or standards, tax laws and regulations, tax rates, and the continuing availability of expected tax benefits;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks relating to the adequacy of our existing infrastructure, systems, processes, policies, procedures, internal controls, and personnel, and our ability to successfully implement and maintain enhancements to the foregoing, for our current and future operations and reporting needs, including related risks of financial statement omissions, misstatements, restatements, or filing delays;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with market volatility in the prices of our common stock and convertible notes based on our performance, third-party or market speculation or publications, or other factors, and risks associated with actions of activist stockholders; and

iii

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with Apax Partners' significant ownership position and potential that its interests will not be aligned with those of our common stockholders.

These risks, uncertainties, assumptions, and challenges, as well as other factors, are discussed in greater detail in "Risk Factors" under Item 1A of our Annual Report on Form 10-K for the year ended January 31, 2025. You are cautioned not to place undue reliance on forward-looking statements, which reflect our management's view only as of the date of this report. We make no commitment to revise or update any forward-looking statements in order to reflect events or circumstances after the date any such statement is made, except as otherwise required under the federal securities laws. If we were in any particular instance to update or correct a forward-looking statement, investors and others should not conclude that we would make additional updates or corrections thereafter except as otherwise required under the federal securities laws.

iv

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

**Part I**

**Item 1. Financial Statements**

---

| | |
|:---|:---|
| **VERINT SYSTEMS INC. AND SUBSIDIARIES** | **VERINT SYSTEMS INC. AND SUBSIDIARIES** |
| **Index to Condensed Consolidated Financial Statements (Unaudited)** | **Index to Condensed Consolidated Financial Statements (Unaudited)** |
| | **Page** |
| [Condensed Consolidated Balance Sheets as of April 30, 2025 and January 31, 2025](#i8df5a199fd074a0db305e1acb96f1d88_22) | [2](#i8df5a199fd074a0db305e1acb96f1d88_22) |
| [Condensed Consolidated Statements of Operations for the Three Months Ended April 30, 2025 and 2024](#i8df5a199fd074a0db305e1acb96f1d88_25) | [3](#i8df5a199fd074a0db305e1acb96f1d88_25) |
| [Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended April 30, 2025 and 2024](#i8df5a199fd074a0db305e1acb96f1d88_28) | [4](#i8df5a199fd074a0db305e1acb96f1d88_28) |
| [Condensed Consolidated Statements of Stockholders' Equity for the Three Months Ended April 30, 2025 and 2024](#i8df5a199fd074a0db305e1acb96f1d88_31) | [5](#i8df5a199fd074a0db305e1acb96f1d88_31) |
| [Condensed Consolidated Statements of Cash Flows for the Three Months Ended April 30, 2025 and 2024](#i8df5a199fd074a0db305e1acb96f1d88_34) | [6](#i8df5a199fd074a0db305e1acb96f1d88_34) |
| [Notes to Condensed Consolidated Financial Statements](#i8df5a199fd074a0db305e1acb96f1d88_37) | [7](#i8df5a199fd074a0db305e1acb96f1d88_37) |

---

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

**VERINT SYSTEMS INC. AND SUBSIDIARIES**

**Condensed Consolidated Balance Sheets**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|<br>(in thousands, except share and per share data) | **April 30,**<br>**2025** | **January 31,**<br>**2025** |
| **Assets** |  |  |
| **Current Assets:** |  |  |
| Cash and cash equivalents | $180870 | $215707 |
| Short-term investments | 449 | 1344 |
| Accounts receivable, net of allowance for credit losses of $1.8 million and $1.8 million, respectively | 172384 | 203113 |
| Contract assets, net | 88783 | 91605 |
| Inventories | 14945 | 14311 |
| Prepaid expenses and other current assets | 58857 | 52692 |
| &nbsp;&nbsp;&nbsp; **Total current assets** | **516288** | **578772** |
| Property and equipment, net | 48364 | 48708 |
| Operating lease right-of-use assets, net | 27365 | 27337 |
| Goodwill | 1417042 | 1386734 |
| Intangible assets, net | 76516 | 80538 |
| Other assets | 172972 | 167960 |
| &nbsp;&nbsp;&nbsp; **Total assets** | $**2258547** | $**2290049** |
| **Liabilities, Temporary Equity, and Stockholders' Equity** |  |  |
| **Current Liabilities:** |  |  |
| Accounts payable | $24026 | $25457 |
| Accrued expenses and other current liabilities | 127407 | 138187 |
| Debt, current | 413117 | 100000 |
| Contract liabilities | 239864 | 255039 |
| &nbsp;&nbsp;&nbsp; **Total current liabilities** | **804414** | **518683** |
| Long-term debt |  | 312753 |
| Long-term contract liabilities | 11208 | 13018 |
| Operating lease liabilities | 28967 | 29094 |
| Other liabilities | 81111 | 90906 |
| &nbsp;&nbsp;&nbsp; **Total liabilities** | **925700** | **964454** |
| **Commitments and Contingencies** |  |  |
| **Temporary Equity:** |  |  |
| **Preferred Stock** — $0.001 par value; authorized 2,207,000 shares |  |  |
| Series A Preferred Stock; 200,000 shares issued and outstanding at April 30, 2025 and January 31, 2025, respectively; aggregate liquidation preference and redemption value of $202,667 and $204,667 at April 30, 2025 and January 31, 2025, respectively. | 200628 | 200628 |
| Series B Preferred Stock; 200,000 shares issued and outstanding at April 30, 2025 and January 31, 2025, respectively; aggregate liquidation preference and redemption value of $202,667 and $204,667 at April 30, 2025 and January 31, 2025, respectively. | 235693 | 235693 |
| &nbsp;&nbsp;&nbsp; **Total temporary equity** | **436321** | **436321** |
| **Stockholders' Equity:** |  |  |
| Common stock — $0.001 par value; authorized 240,000,000 shares; issued 60,248,000 and 62,135,000 shares; outstanding 60,248,000 and 62,135,000 shares at April 30, 2025 and January 31, 2025, respectively. | 60 | 62 |
| Additional paid-in capital | 953080 | 981862 |
| Retained earnings | 59486 | 57864 |
| Accumulated other comprehensive loss | (118817) | (152939) |
| **Total Verint Systems Inc. stockholders' equity** | **893809** | **886849** |
| Noncontrolling interest | 2717 | 2425 |
| &nbsp;&nbsp;&nbsp; **Total stockholders' equity** | **896526** | **889274** |
| &nbsp;&nbsp;&nbsp; **Total liabilities, temporary equity, and stockholders' equity** | $**2258547** | $**2290049** |

---

See notes to condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

**VERINT SYSTEMS INC. AND SUBSIDIARIES**

**Condensed Consolidated Statements of Operations**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended <br>April 30,** | **Three Months Ended <br>April 30,** |
|<br>(in thousands, except per share data) | **2025** | **2024** |
| **Revenue:** |  |  |
| Recurring | $173623 | $173528 |
| Nonrecurring perpetual | 17021 | 24900 |
| Nonrecurring professional services and other | 17453 | 22849 |
| &nbsp;&nbsp;&nbsp; **Total revenue** | **208097** | **221277** |
| **Cost of revenue:** |  |  |
| Recurring | 42108 | 35923 |
| Nonrecurring perpetual | 7248 | 8774 |
| Nonrecurring professional services and other | 17531 | 17706 |
| Amortization of acquired technology | 2308 | 1358 |
| &nbsp;&nbsp;&nbsp; **Total cost of revenue** | **69195** | **63761** |
| **Gross profit** | **138902** | **157516** |
| **Operating expenses:** |  |  |
| Research and development, net | 40641 | 36730 |
| Selling, general and administrative | 89670 | 93276 |
| Amortization of other acquired intangible assets | 3519 | 3065 |
| &nbsp;&nbsp;&nbsp; **Total operating expenses** | **133830** | **133071** |
| **Operating income** | **5072** | **24445** |
| **Other income (expense), net:** |  |  |
| Interest income | 1463 | 1978 |
| Interest expense | (2499) | (2591) |
| Other income (expense), net | 496 | (498) |
| &nbsp;&nbsp;&nbsp; **Total other expense, net** | **(540)** | **(1111)** |
| **Income before provision for income taxes** | **4532** | **23334** |
| Provision for income taxes | 2605 | 7955 |
| **Net income** | **1927** | **15379** |
| Net income attributable to noncontrolling interests | 305 | 138 |
| **Net income attributable to Verint Systems Inc.** | **1622** | **15241** |
| Dividends on preferred stock | (4000) | (5200) |
| **Net (loss) income attributable to Verint Systems Inc. common shares** | $**(2378)** | $**10041** |
| **Net (loss) income per common share attributable to Verint Systems Inc.:** |  |  |
| **Basic** | $**(0.04)** | $**0.16** |
| **Diluted** | $**(0.04)** | $**0.16** |
| **Weighted-average common shares outstanding:** |  |  |
| **Basic** | **61916** | **62335** |
| **Diluted** | **61916** | **62845** |

---

See notes to condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

**VERINT SYSTEMS INC. AND SUBSIDIARIES**

**Condensed Consolidated Statements of Comprehensive Income**

**(Unaudited)** 

---

| | | |
|:---|:---|:---|
| | **Three Months Ended <br>April 30,** | **Three Months Ended <br>April 30,** |
|<br>(in thousands) | **2025** | **2024** |
| **Net income** | $**1927** | $**15379** |
| **Other comprehensive income (loss), net of reclassification adjustments:** |  |  |
| Foreign currency translation adjustments | 34219 | (7060) |
| Net decrease from foreign exchange contracts designated as hedges | (116) | (266) |
| Benefit from income taxes on net decrease from foreign exchange contracts designated as hedges | 19 | 47 |
| **Other comprehensive income (loss)** | **34122** | **(7279)** |
| **Comprehensive income** | **36049** | **8100** |
| Comprehensive income attributable to noncontrolling interests | 305 | 138 |
| **Comprehensive income attributable to Verint Systems Inc.** | $**35744** | $**7962** |

---

See notes to condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

**VERINT SYSTEMS INC. AND SUBSIDIARIES**

**Condensed Consolidated Statements of Stockholders' Equity**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Verint Systems Inc. Stockholders' Equity** | **Verint Systems Inc. Stockholders' Equity** | **Verint Systems Inc. Stockholders' Equity** | **Verint Systems Inc. Stockholders' Equity** | **Verint Systems Inc. Stockholders' Equity** | **Verint Systems Inc. Stockholders' Equity** | | |
| | **Common Stock** | **Common Stock** | **Additional Paid-in Capital** | **Retained Earnings / (Accumulated**<br>**Deficit)** | **Accumulated Other Comprehensive Loss** | **Total Verint Systems Inc. Stockholders' Equity** | | **Total Stockholders' Equity** |
|<br>(in thousands) | **Shares** | **Par<br>Value** | **Additional Paid-in Capital** | **Retained Earnings / (Accumulated**<br>**Deficit)** | **Accumulated Other Comprehensive Loss** | **Total Verint Systems Inc. Stockholders' Equity** |<br>**Non-controlling<br>Interests** | **Total Stockholders' Equity** |
| **Balances as of January 31, 2025** | **62135** | $**62** | $**981862** | $**57864** | $**(152939)** | $**886849** | $**2425** | $**889274** |
| Net income |  |  |  | 1622 |  | 1622 | 305 | **1927** |
| Other comprehensive income |  |  |  |  | 34122 | 34122 |  | **34122** |
| Stock-based compensation — equity-classified awards |  |  | 13540 |  |  | 13540 |  | **13540** |
| Common stock issued for stock awards and stock bonuses | 645 |  |  |  |  |  |  | **—** |
| Common stock repurchased and retired | (2532) | (2) | (42322) |  |  | (42324) |  | **(42324)** |
| Distribution to noncontrolling interest |  |  |  |  |  |  | (13) | **(13)** |
| **Balances as of April 30, 2025** | **60248** | $**60** | $**953080** | $**59486** | $**(118817)** | $**893809** | $**2717** | $**896526** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Balances as of January 31, 2024** | **62738** | $**63** | $**979671** | $**(6723)** | $**(142962)** | $**830049** | $**2617** | $**832666** |
| Net income |  |  |  | 15241 |  | 15241 | 138 | **15379** |
| Other comprehensive loss |  |  |  |  | (7279) | (7279) |  | **(7279)** |
| Stock-based compensation — equity-classified awards |  |  | 16508 |  |  | 16508 |  | **16508** |
| Common stock issued for stock awards and stock bonuses | 410 |  |  |  |  |  |  | **—** |
| Common stock repurchased and retired | (1234) | (1) | (38117) |  |  | (38118) |  | **(38118)** |
| Distribution to noncontrolling interest |  |  |  |  |  |  | (245) | **(245)** |
| **Balances as of April 30, 2024** | **61914** | $**62** | $**958062** | $**8518** | $**(150241)** | $**816401** | $**2510** | $**818911** |

---

See notes to condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

**VERINT SYSTEMS INC. AND SUBSIDIARIES**

**Condensed Consolidated Statements of Cash Flows**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** |
|<br>(in thousands) | **2025** | **2024** |
| **Cash flows from operating activities:** |  |  |
| Net income | $1927 | $15379 |
| **Adjustments to reconcile net income to net cash provided by operating activities:** |  |  |
| Depreciation and amortization | 12973 | 11367 |
| Stock-based compensation, excluding cash-settled awards | 15428 | 18009 |
| Other, net | (6657) | 179 |
| **Changes in operating assets and liabilities, net of effects of business combinations and divestitures:** |  |  |
| Accounts receivable | 32864 | 33802 |
| Contract assets | 3807 | (4776) |
| Inventories | (908) | (2372) |
| Prepaid expenses and other assets | (9925) | 1404 |
| Accounts payable and accrued expenses | (155) | (2410) |
| Contract liabilities | (21465) | (12418) |
| Deferred income taxes | 2106 | 775 |
| Other, net | (3672) | 1778 |
| **Net cash provided by operating activities** | **26323** | **60717** |
| **Cash flows from investing activities:** |  |  |
| Cash paid for asset acquisitions and business combinations, including adjustments, net of cash acquired | (299) | (9206) |
| Divestitures, net of cash divested |  | 1300 |
| Purchases of property and equipment | (3168) | (3591) |
| Purchases of investments |  | (330) |
| Maturities and sales of investments | 908 | 228 |
| Cash paid for capitalized software development costs | (2857) | (2538) |
| Change in restricted bank time deposits, and other investing activities, net | (5) | 2 |
| **Net cash used in investing activities** | **(5421)** | **(14135)** |
| **Cash flows from financing activities:** |  |  |
| Repayments of borrowings and other financing obligations | (254) | (553) |
| Purchases of treasury stock and common stock for retirement | (41843) | (37095) |
| Preferred stock dividend payments | (8000) | (10400) |
| Payments of debt-related costs | (2166) | (10) |
| Distributions paid to noncontrolling interest | (13) | (245) |
| Payments of contingent consideration for business combinations and asset acquisitions (financing portion) | (6831) | (2658) |
| Cash received for contingent consideration for business divestitures (financing portion) | 224 | 224 |
| **Net cash used in financing activities** | **(58883)** | **(50737)** |
| Foreign currency effects on cash, cash equivalents, restricted cash, and restricted cash equivalents | 3144 | (848) |
| **Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents** | **(34837)** | **(5003)** |
| **Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period** | **215707** | **242669** |
| **Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period** | $**180870** | $**237666** |
| **Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period to the condensed consolidated balance sheets:** |  |  |
| Cash and cash equivalents | $180870 | $236592 |
| Restricted cash and cash equivalents included in prepaid expenses and other current assets |  | 1074 |
| **Total cash, cash equivalents, restricted cash, and restricted cash equivalents** | $**180870** | $**237666** |

---

See notes to condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

**VERINT SYSTEMS INC. AND SUBSIDIARIES**

**Notes to Condensed Consolidated Financial Statements**

***1.&nbsp;&nbsp;&nbsp;&nbsp;BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES***

***Description of Business***

Unless the context otherwise requires, the terms "Verint", "we", "us", and "our" in these notes to condensed consolidated financial statements refer to Verint Systems Inc. and its consolidated subsidiaries.

Verint is a leader in customer experience ("CX") automation with a customer base that includes more than 80 of the Fortune 100 companies. The world's most iconic brands use the Verint Open Platform and our team of AI-powered bots to deliver tangible AI business outcomes across the enterprise. Verint is uniquely positioned to help brands increase CX automation with our differentiated AI-powered Open Platform.

Verint is headquartered in Melville, New York, and has approximately 15 offices worldwide, in addition to a number of on-demand, flexible coworking spaces. We have approximately 3,700 employees plus a few hundred contractors around the globe.

***Apax Convertible Preferred Stock Investment***

On December 4, 2019, we announced that an affiliate (the "Apax Investor") of Apax Partners ("Apax") would make an investment in us in an amount of up to $400.0 million. Under the terms of the Investment Agreement, dated as of December 4, 2019 (the "Investment Agreement"), on May 7, 2020, the Apax Investor purchased $200.0 million of our Series A convertible preferred stock ("Series A Preferred Stock"). On February 1, 2021, we completed the spin-off (the "Spin-Off") of Cognyte Software Ltd. ("Cognyte"), a company limited by shares incorporated under the laws of the State of Israel whose business and operations consist of our former Cyber Intelligence Solutions business. In connection with the completion of the Spin-Off, on April 6, 2021, the Apax Investor purchased $200.0 million of our Series B convertible preferred stock (the "Series B Preferred Stock" and together with the Series A Preferred Stock, the "Preferred Stock"). As of April 30, 2025, Apax's ownership in us on an as-converted basis was approximately 13.7%. Please refer to Note 9, "Convertible Preferred Stock" for a more detailed discussion of the Apax investment.

***Preparation of Condensed Consolidated Financial Statements***

The condensed consolidated financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and on the same basis as the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended January 31, 2025 filed with the U.S. Securities and Exchange Commission ("SEC"). The condensed consolidated statements of operations, comprehensive income, stockholders' equity, and cash flows for the periods ended April 30, 2025 and 2024, and the condensed consolidated balance sheet as of April 30, 2025, are not audited but reflect all adjustments that, in the opinion of management, are of a normal recurring nature and that are considered necessary for a fair presentation of the results for the periods shown. The condensed consolidated balance sheet as of January 31, 2025 is derived from the audited consolidated financial statements presented in our Annual Report on Form 10-K for the year ended January 31, 2025. Certain information and disclosures normally included in annual consolidated financial statements have been omitted pursuant to the rules and regulations of the SEC. Because the condensed consolidated interim financial statements do not include all of the information and disclosures required by GAAP for a complete set of financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the year ended January 31, 2025 filed with the SEC. The results for interim periods are not necessarily indicative of a full year's results.

***Principles of Consolidation***

The accompanying condensed consolidated financial statements include the accounts of Verint Systems Inc., and our wholly owned or otherwise controlled subsidiaries. Noncontrolling interests in less than wholly owned subsidiaries are reflected within stockholders' equity on our condensed consolidated balance sheet, but separately from our stockholders' equity.

Equity investments in companies in which we have less than a 20% ownership interest and cannot exercise significant influence, and which do not have readily determinable fair values, are accounted for at cost, adjusted for changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer, less any impairment.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

We include the results of operations of acquired companies from the date of acquisition. All significant intercompany transactions and balances are eliminated.

***Use of Estimates***

The preparation of financial statements in conformity with GAAP requires our management to make estimates and assumptions, which may affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Key estimates in the accompanying condensed consolidated financial statements include, among others, revenue recognition, allowances for doubtful accounts, determining the fair value of assets and liabilities assumed in business combinations, recoverability of goodwill, amortization of intangibles, evaluation of contingencies, and the accounting for income taxes. Actual results could differ from those estimates.

***Significant Accounting Policies***

There have been no material changes in our significant accounting policies during the three months ended April 30, 2025, as compared to the significant accounting policies described in Note 1 to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended January 31, 2025.

***Recently Adopted Accounting Pronouncements***

There have been no recently adopted accounting pronouncements since the filing of our Annual Report on Form 10-K for the year ended January 31, 2025 that may have a material impact on our condensed consolidated financial statements.

***New Accounting Pronouncements Not Yet Effective***

In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-09, *Income Taxes (Topic 740): Improvements to Income Tax Disclosures,* which will require greater disaggregation of a reporting entity's effective tax rate reconciliation as well as income taxes paid. ASU No. 2023-09 will be effective for our Annual Report on Form 10-K for the year ending January 31, 2026 and can be applied on a prospective or retrospective basis. As the guidance is a change to disclosure only, it will impact disclosures in our "Income Taxes" footnote within our annual financial statements but will not impact the consolidated financial results.

In November 2024, the FASB issued ASU No. 2024-03, *Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures*, which will require additional disclosure of the nature of expenses included in the income statement, including disclosures about the specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. ASU No. 2024-03 is effective for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027 on a prospective basis, with early adoption and retrospective adoption permitted. We are currently evaluating the impact of this standard on our condensed consolidated financial statements and disclosures.

In November 2024, the FASB issued ASU 2024-04, *Debt with Conversion and Other Options (Subtopic 470-20)*, which clarifies the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. The ASU is effective for annual and interim reporting periods beginning after December 15, 2025. Early adoption is permitted for entities that have implemented ASU 2020-06, *Debt - Debt With Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40),* with the option to apply the guidance prospectively or retrospectively. We are currently assessing the impact of this standard on our condensed consolidated financial statements.

***2.&nbsp;&nbsp;&nbsp;&nbsp;REVENUE RECOGNITION***

We derive our revenue primarily from providing customers the right to access our cloud-based solutions, the right to use our software for an indefinite or specified period of time, and related services and support based on when access or control of the software passes to our customers or the services are provided, in an amount that reflects the consideration we expect to be entitled to in exchange for such goods or services. Revenue is reported net of applicable sales and use tax, value-added tax and other transaction taxes imposed on the related transactions, including mandatory government charges that are passed through to our customers.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

We determine revenue recognition through the following five steps:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Identification of the contract, or contracts, with a customer

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Identification of the performance obligations in the contract

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Determination of the transaction price

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Allocation of the transaction price to the performance obligations in the contract

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Recognition of revenue when, or as, performance obligations are satisfied.

We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance, and collectability of consideration is probable.

**Disaggregation of Revenue**

The following table provides a disaggregation of our recurring and nonrecurring revenue. Recurring revenue is the portion of our revenue that we believe is likely to be renewed in the future. The recurrence of these revenue streams in future periods depends on a number of factors including contractual periods and customers' renewal decisions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Recurring revenue primarily consists of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Software as a service ("SaaS") revenue, which consists predominately of bundled SaaS (software access rights with standard managed services) and unbundled SaaS (software licensing rights accounted for as term-based licenses whereby customers have a license to our software with related support for a specific period).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;▪ Bundled SaaS revenue is recognized over time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;▪ Unbundled SaaS revenue is recognized at a point in time, except for the related support which is recognized over time. Unbundled SaaS contracts are eligible for renewal after the initial fixed term, which in most cases is between a one- and three-year time frame. Unbundled SaaS can be deployed in the cloud, either by us or a cloud partner, or in a customer's data center or premises.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Optional managed services revenue including hosting services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Support revenue, which consists of initial and renewal support on our perpetual licenses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Nonrecurring perpetual revenue primarily consists of our perpetual licenses and hardware.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Nonrecurring professional services and other revenue primarily consists of our installation services, business advisory consulting and training services, and patent royalties.

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** |
|<br>(in thousands) | **2025** | **2024** |
| **Recurring revenue:** |  |  |
| Bundled SaaS revenue | $81257 | $65695 |
| Unbundled SaaS revenue | 66227 | 75288 |
| &nbsp;&nbsp;**Total SaaS revenue** | **147484** | **140983** |
| Optional managed services revenue | 5014 | 5168 |
| Support revenue | 21125 | 27377 |
| &nbsp;&nbsp;**Total recurring revenue** | **173623** | **173528** |
| **Nonrecurring perpetual revenue** | **17021** | **24900** |
| **Nonrecurring professional services and other revenue** | **17453** | **22849** |
| &nbsp;&nbsp;**Total revenue** | $**208097** | $**221277** |

---

**Contract Balances**

The following table provides information about accounts receivable, contract assets, and contract liabilities from contracts with customers:

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

---

| | | |
|:---|:---|:---|
| (in thousands) | **April 30, 2025** | **January 31, 2025** |
| Accounts receivable, net | $172384 | $203113 |
| Contract assets, net | $88783 | $91605 |
| Long-term contract assets, net (included in other assets) | $38382 | $32822 |
| Contract liabilities | $239864 | $255039 |
| Long-term contract liabilities | $11208 | $13018 |

---

We receive payments from customers based upon contractual billing schedules, and accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets are rights to consideration in exchange for goods or services that we have transferred to a customer when that right is conditional on something other than the passage of time. The majority of our contract assets represent unbilled amounts related to multi-year unbundled SaaS contracts and arrangements where our right to consideration is subject to the contractually agreed upon billing schedule. We expect billing and collection of a majority of our contract assets to occur within the next twelve months and asset impairment charges related to contract assets were immaterial in the three months ended April 30, 2025 and 2024. As of April 30, 2025, three partners, all authorized global resellers of our solutions, accounted for more than 10% of our aggregated accounts receivable and contract assets; Partner A and Partner C were approximately 11% and Partner B was approximately 17%. As of January 31, 2025, Partner A was approximately 11% and Partner B was approximately 14% of our aggregated accounts receivable and contract assets. Partner C did not account for more than 10% of our aggregated accounts receivable and contract assets as of January 31, 2025. Credit losses relating to these customers have historically been immaterial.

Contract liabilities represent consideration received or consideration which is unconditionally due from customers prior to transferring goods or services to the customer under the terms of the contract. Revenue recognized during the three months ended April 30, 2025 and 2024 from amounts included in contract liabilities at the beginning of each period was $102.1 million and $99.1 million, respectively.

**Remaining Performance Obligations**

Transaction price allocated to remaining performance obligations represents contracted revenue that has not yet been recognized, which includes contract liabilities and non-cancelable amounts that will be invoiced and recognized as revenue in future periods. The majority of our arrangements are for periods of one to three years, although the contract term can extend up to five years.

We elected to exclude amounts of variable consideration attributable to sales- or usage-based royalties in exchange for a license of our IP from the remaining performance obligations. The timing and amount of revenue recognition for our remaining performance obligations are influenced by several factors, including seasonality, the timing of renewals, the timing of delivery of software licenses, the average length of the contract terms, and foreign currency exchange rates.

The following table provides information about when we expect to recognize our remaining performance obligations:

---

| | | |
|:---|:---|:---|
| (in thousands) | **April 30, 2025** | **January 31, 2025** |
| **Remaining performance obligations:** |  |  |
| Expected to be recognized within 1 year | $433932 | $441360 |
| Expected to be recognized in more than 1 year | 287766 | 300615 |
| &nbsp;&nbsp;**Total remaining performance obligations**  | $**721698** | $**741975** |

---

***3.&nbsp;&nbsp;&nbsp;&nbsp;NET (LOSS) INCOME PER COMMON SHARE ATTRIBUTABLE TO VERINT SYSTEMS INC.***

The following table summarizes the calculation of basic and diluted net (loss) income per common share attributable to Verint Systems Inc. for the three months ended April 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** |
|<br>(in thousands, except per share amounts) | **2025** | **2024** |
| Net income | $1927 | $15379 |

---

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** |
|<br>(in thousands, except per share amounts) | **2025** | **2024** |
| Net income attributable to noncontrolling interests | 305 | 138 |
| **Net income attributable to Verint Systems Inc.** | **1622** | **15241** |
| Dividends on preferred stock | (4000) | (5200) |
| **Net (loss) income attributable to Verint Systems Inc. for basic net loss per common share** | **(2378)** | **10041** |
| Dilutive effect of dividends on preferred stock |  |  |
| **Net (loss) income attributable to Verint Systems Inc. for diluted net income per common share** | $**(2378)** | $**10041** |
| **Weighted-average shares outstanding:** |  |  |
| &nbsp;&nbsp;&nbsp;**Basic** | **61916** | **62335** |
| &nbsp;&nbsp;&nbsp;Dilutive effect of employee equity award plans |  | 510 |
| &nbsp;&nbsp;&nbsp;Dilutive effect of 2021 Notes |  |  |
| &nbsp;&nbsp;Dilutive effect of assumed conversion of preferred stock |  |  |
| &nbsp;&nbsp;&nbsp;**Diluted** | **61916** | **62845** |
| **Net (loss) income per common share attributable to Verint Systems Inc.:** |  |  |
| &nbsp;&nbsp;**Basic** | $**(0.04)** | $**0.16** |
| &nbsp;&nbsp;**Diluted** | $**(0.04)** | $**0.16** |

---

We excluded the following weighted-average potential common shares from the calculations of diluted net (loss) income per common share during the applicable periods because their inclusion would have been anti-dilutive:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** |
|<br>(in thousands) | **2025** | **2024** |
| **Common shares excluded from calculation:** |  |  |
| Restricted and performance stock-based awards | 3133 | 1733 |
| Series A Preferred Stock | 5498 | 5498 |
| Series B Preferred Stock | 3980 | 3980 |

---

In periods for which we report a net loss attributable to Verint Systems Inc. common shares, basic net loss per common share and diluted net loss per common share are identical since the effect of all potential common shares is anti-dilutive and therefore excluded.

For the three months ended April 30, 2025, the average price of our common stock did not exceed the $62.08 per share conversion price of our 2021 Notes, and other requirements for the 2021 Notes (as defined in Note 7, "Debt"), to be convertible were not met. The 2021 Notes will have a dilutive impact on net income per common share at any time when the average market price of our common stock for a quarterly reporting period exceeds the conversion price.

The Capped Calls (as defined in Note 7, "Debt") do not impact our diluted earnings per common share calculations as their effect would be anti-dilutive. The Capped Calls are generally intended to reduce the potential dilution to our common stock upon any conversion of the 2021 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2021 Notes, in the event that at the time of conversion our common stock price exceeds the $62.08 conversion price, with such reduction and/or offset subject to a cap of $100.00.

Further details regarding the 2021 Notes and Capped Calls appear in Note 7, "Debt".

The weighted-average common shares underlying the assumed conversion of the Preferred Stock, on an as-converted basis, were excluded from the calculations of diluted net (loss) income per common share for the three months ended April 30, 2025 and 2024, as their effect would have been anti-dilutive. Further details regarding the Preferred Stock investment appear in Note 9, "Convertible Preferred Stock".

***4.&nbsp;&nbsp;&nbsp;&nbsp;CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS***

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

The following tables summarize our cash, cash equivalents, and short-term investments as of April 30, 2025 and January 31, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **April 30, 2025** | **April 30, 2025** | **April 30, 2025** | **April 30, 2025** |
|<br>(in thousands) | **Cost Basis** | **Gross Unrealized Gains** | **Gross Unrealized Losses** | **Estimated Fair Value** |
| **Cash and cash equivalents:** |  |  |  |  |
| Cash and bank time deposits | $152138 | $— | $— | $152138 |
| Money market funds | 28483 |  |  | 28483 |
| U.S. Treasury bills | 249 |  |  | 249 |
| &nbsp;&nbsp;**Total cash and cash equivalents** | $**180870** | $**—** | $**—** | $**180870** |
| **Short-term investments:** |  |  |  |  |
| Bank time deposits | $449 | $— | $— | $449 |
| &nbsp;&nbsp;**Total short-term investments** | $**449** | $**—** | $**—** | $**449** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **January 31, 2025** | **January 31, 2025** | **January 31, 2025** | **January 31, 2025** |
|<br>(in thousands) | **Cost Basis** | **Gross Unrealized Gains** | **Gross Unrealized Losses** | **Estimated Fair Value** |
| **Cash and cash equivalents:** |  |  |  |  |
| Cash and bank time deposits | $159688 | $— | $— | $159688 |
| Money market funds | 56019 |  |  | 56019 |
| &nbsp;&nbsp;**Total cash and cash equivalents** | $**215707** | $**—** | $**—** | $**215707** |
| **Short-term investments:** |  |  |  |  |
| Bank time deposits | $1344 | $— | $— | $1344 |
| &nbsp;&nbsp;**Total short-term investments** | $**1344** | $**—** | $**—** | $**1344** |

---

Bank time deposits which are reported within short-term investments consist of deposits held outside of the United States with maturities of greater than 90 days, or without specified maturity dates which we intend to hold for periods in excess of 90 days. All other bank deposits are included within cash and cash equivalents.

During the three months ended April 30, 2025 and 2024, proceeds from maturities and sales of short-term investments were $0.9 million and $0.2 million, respectively.

***5.&nbsp;&nbsp;&nbsp;&nbsp;BUSINESS COMBINATIONS AND ASSET ACQUISITIONS***

***Three Months Ended April 30, 2025***

We did not complete any business combinations during the three months ended April 30, 2025.

***Year Ended January 31, 2025***

**Cogito Corporation**

On October 11, 2024, we acquired the assets of Cogito Corporation ("Cogito"), a leading provider of AI solutions, including approximately 50 employees in technology functions. Cogito is based in Boston, Massachusetts. The transaction was accounted for as a business combination, after determining that the acquired set of assets, the fair value of which was not concentrated in a single asset, or group of similar assets, and included (a) an assembled workforce and (b) intangible assets, met the definition of a business.

Revenue and net income (loss) attributable to Cogito included in our condensed consolidated statement of operations for the three months ended April 30, 2025 was not material.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

The purchase price consisted of (i) $38.2 million of cash paid at closing, funded from cash on hand, (ii) the fair value of the contingent consideration arrangements estimated at $11.8 million as of the acquisition date, and (iii) $0.3 million of other purchase price adjustments. These contingent consideration arrangements provide for potential additional cash payments to the sellers aggregating up to approximately $19.0 million, contingent upon the achievement of certain performance targets extending through October 2026. We also established a key employee incentive plan for certain former non-owner key employees of Cogito that provides for contingent payments of up to $4.2 million based on achievement of certain performance targets through October 2026. These payments are not contingent upon continued employment and are accounted for separately from the business combination purchase consideration. As of April 30, 2025, we concluded that the payment of the contingent amount was no longer probable, leading to a reversal of the $3.5 million accrual we recorded during the year ended January 31, 2025. This reversal was recognized as a reduction of $1.8 million in selling, general and administrative expenses and a reduction of $1.7 million in research and development expenses on our condensed consolidated statement of operations during the three months ended April 30, 2025.

The purchase price for Cogito was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values on the acquisition date, with the remaining unallocated purchase price recorded as goodwill. The fair values assigned to identifiable intangible assets acquired were determined primarily by using the income approach, which discounts the expected future cash flows to present value using estimates and assumptions determined by management.

Among the factors contributing to the recognition of goodwill as a component of the Cogito purchase price allocation were synergies in products and technologies, and the addition of a skilled, assembled workforce. The acquisition resulted in the recognition of $27.1 million of goodwill. This transaction is accounted for as an asset acquisition for tax purposes, and therefore both the goodwill and acquired intangible assets are deductible for tax purposes. Tax impacts were not material.

Transaction and related costs directly related to the acquisition of Cogito, consisting primarily of professional fees and integration expenses, were $1.5 million for the three months ended April 30, 2025, of which $0.7 million is included in selling, general and administrative expenses, $0.6 million is included in research and development expenses, and $0.2 million is included in cost of recurring revenue.

The purchase price allocation for Cogito has been prepared on a preliminary basis and changes to the allocation may occur as additional information becomes available during the measurement period (up to one year from the acquisition date). Fair values still under review include values assigned to identifiable intangible assets.

The following table sets forth the components and the allocation of the purchase price for our acquisition of Cogito:

---

| | |
|:---|:---|
| (in thousands) | **Amount** |
| **Components of Purchase Price:** |  |
| &nbsp;&nbsp;&nbsp;Cash | $38186 |
| &nbsp;&nbsp;&nbsp;Fair value of contingent consideration | 11786 |
| &nbsp;&nbsp;Other purchase price adjustments | 299 |
| **Total purchase price** | $**50271** |
| **Allocation of Purchase Price:** |  |
| **Net tangible assets (liabilities):** |  |
| &nbsp;&nbsp;&nbsp;Accounts receivable | 6236 |
| &nbsp;&nbsp;&nbsp;Other current assets, including cash acquired | 2402 |
| &nbsp;&nbsp;&nbsp;Current and other liabilities | (3177) |
| &nbsp;&nbsp;Contract liabilities — current and long-term | (8047) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net tangible liabilities** | **(2586)** |
| **Identifiable intangible assets:** |  |
| &nbsp;&nbsp;&nbsp;Customer relationships | 14300 |
| &nbsp;&nbsp;&nbsp;Developed technology | 11500 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total identifiable intangible assets** | **25800** |
| **Goodwill** | **27057** |
| **Total purchase price allocation** | $**50271** |

---

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

The acquired customer relationships and developed technology were assigned estimated useful lives of seven and five years, respectively, the weighted average of which is approximately 6.1 years. The acquired identifiable intangible assets are being amortized on a straight-line basis, which we believe approximates the pattern in which the assets are utilized over their estimated useful lives.

**Other Business Combinations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** In April 2024, we completed the acquisition of an AI-powered analytics company, including 14 employees. Pursuant to the terms of the purchase agreement, the purchase price consisted of $8.8 million of cash paid at closing, contingent consideration with an estimated fair value of $3.4 million, and the acquisition date fair value of our previously held investment via a simple agreement for future equity ("SAFE"), which was approximately $1.7 million. Further discussion regarding this SAFE investment appears in Note 12, "Fair Value Measurements". We recognized intangible assets of $5.2 million for developed technology, $0.2 million for the acquired customer relationships, and goodwill of $8.2 million. The acquisition qualified as a stock transaction for tax purposes. This transaction was not material to our condensed consolidated financial statements, and as a result, additional business combination disclosures for this acquisition have been omitted.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***•*** In May 2024, we completed the acquisition of a provider of cloud-based call-back solutions, including nine employees. This transaction resulted in the recognition of $3.2 million of goodwill, $0.3 million of acquired customer relationships, and $1.0 million of developed technology intangible assets, but was not material to our condensed consolidated financial statements, and as a result, additional business combination disclosures for this acquisition have been omitted.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** In October 2024, we completed the acquisition of a provider of data analytics solutions, including approximately 25 employees in technology functions. This transaction resulted in the recognition of $5.9 million of goodwill, $5.1 million of developed technology intangible assets, and $0.5 million of acquired customer relationships, but was not material to our condensed consolidated financial statements and, as a result, additional business combination disclosures for this acquisition have been omitted.

Revenue and net income (loss) attributable to these acquisitions for the three months ended April 30, 2025 and 2024 was not material.

***Other Business Combination Information***

For the three months ended April 30, 2025 and 2024, we recorded a benefit of $7.7 million and $0.4 million, respectively, within selling, general and administrative expenses for changes in the fair values of contingent consideration obligations associated with business combinations, which was based on the probability of our historical business combinations achieving certain objectives and milestones. The current period benefit is primarily a result of revised outlooks related to a recent acquisition. The aggregate fair values of the remaining contingent consideration obligations associated with business combinations was $8.2 million at April 30, 2025, of which $5.6 million was recorded within accrued expenses and other current liabilities, and $2.6 million was recorded within other liabilities.

Payments of contingent consideration earned under these agreements were $6.4 million and $3.3 million for the three months ended April 30, 2025 and 2024, respectively.

***Asset Acquisitions***

In November 2024, we entered into an agreement to acquire source code that qualified as an asset acquisition for an initial cash purchase price of $2.2 million, plus up to a maximum of $0.4 million in additional cash payments based on the achievement of certain integration milestones. Direct transaction costs related to such asset acquisition were immaterial.

In July 2023, we entered into an agreement to acquire source code that qualified as an asset acquisition and made an initial deposit payment of $1.0 million upon the execution of the contract and incurred direct transaction costs related to such asset acquisition of $0.2 million. The agreement also stipulated the establishment of additional milestone payments totaling $3.0 million, of which $2.0 million was deposited into a third-party escrow account in connection with the closing of the transaction. These milestone payments were contingent upon the successful delivery of the source code and the attainment of specific developmental objectives. During the year ended January 31, 2024, we made $1.8 million in milestone payments to the seller. During the year ended January 31, 2025, we made the final $1.0 million of development milestone payments to the seller, and closed the escrow account.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

The transaction also provides for additional consideration of up to $5.0 million that is contingent upon achieving certain performance targets for the years ending January 31, 2025 and 2026. Of this amount, $2.0 million became guaranteed during the year ended January 31, 2025 as a result of the development milestones outlined above being achieved by the agreed upon dates. The agreement also includes the opportunity to receive additional payments from us based on any revenue we receive from sales of products based on the acquired technology in adjacent markets. During the year ended January 31, 2025, we made a $0.3 million noncontingent prepayment against the first period earn-out, and accrued the remaining $1.7 million of the minimum guaranteed contingent consideration upon achieving certain milestones by certain dates. During the three months ended April 30, 2025, we made a $0.7 million payment against the first period earn-out, with the remaining $1.0 million recorded within accrued expenses and other current liabilities as of April 30, 2025. Contingent consideration is not recorded in an asset acquisition until the contingency is resolved (when the contingent consideration is paid or becomes payable) or when probable and reasonably estimable.

***6.&nbsp;&nbsp;&nbsp;&nbsp;INTANGIBLE ASSETS AND GOODWILL***

Acquisition-related intangible assets, excluding certain intangible assets previously acquired that were fully amortized and intangible assets of the businesses we divested which were removed from our condensed consolidated balance sheets, consisted of the following as of April 30, 2025 and January 31, 2025:

---

| | | | |
|:---|:---|:---|:---|
| | **April 30, 2025** | **April 30, 2025** | **April 30, 2025** |
|<br>(in thousands) | **Cost** | **Accumulated<br>Amortization** | **Net** |
| **Intangible assets with finite lives:** |  |  |  |
| Customer relationships | $477771 | $(435483) | $42288 |
| Acquired technology | 256577 | (222349) | 34228 |
| Other | 6040 | (6040) |  |
| &nbsp;&nbsp;&nbsp;**Total intangible assets** | $**740388** | $**(663872)** | $**76516** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **January 31, 2025** | **January 31, 2025** | **January 31, 2025** |
|<br>(in thousands) | **Cost** | **Accumulated<br>Amortization** | **Net** |
| **Intangible assets with finite lives:** |  |  |  |
| Customer relationships | $466959 | $(422067) | $44892 |
| Acquired technology | 250183 | (214537) | 35646 |
| Other | 6040 | (6040) |  |
| **&nbsp;&nbsp;&nbsp;&nbsp;Total intangible assets** | $**723182** | $**(642644)** | $**80538** |

---

Total amortization expense recorded for acquisition-related intangible assets was $5.8 million and $4.4 million for the three months ended April 30, 2025 and 2024, respectively. The reported amount of net acquisition-related intangible assets can fluctuate from the impact of changes in foreign currency exchange rates on intangible assets not denominated in U.S. dollars.

Estimated future amortization expense on finite-lived acquisition-related intangible assets is as follows:

---

| | |
|:---|:---|
| (in thousands) |  |
| **Years Ending January 31,** | **Amount** |
| 2026 (remainder of year) | $18512 |
| 2027 | 20989 |
| 2028 | 16036 |
| 2029 | 10665 |
| 2030 | 6293 |
| 2031 and thereafter | 4021 |
| **Total** | $**76516** |

---

There were no impairments of acquired intangible assets during the three months ended April 30, 2025 and 2024.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

Goodwill activity for the three months ended April 30, 2025 was as follows:

---

| | |
|:---|:---|
| (in thousands) | **Amount** |
| **Three Months Ended April 30, 2025:** |  |
| Goodwill, gross, at January 31, 2025 | $1442777 |
| Accumulated impairment losses through January 31, 2025 | (56043) |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill, net, at January 31, 2025 | 1386734 |
| Foreign currency translation | 30389 |
| Business combinations, including adjustments to prior period acquisitions | (81) |
| **Goodwill, net, at April 30, 2025** | $**1417042** |
| **Balance at April 30, 2025** |  |
| Goodwill, gross, at April 30, 2025 | $1473085 |
| Accumulated impairment losses through April 30, 2025 | (56043) |
| **Goodwill, net, at April 30, 2025** | $**1417042** |

---

No events or circumstances indicating the potential for goodwill impairment were identified during the three months ended April 30, 2025.

***7.&nbsp;&nbsp;&nbsp;&nbsp;DEBT***

The following table summarizes our debt at April 30, 2025 and January 31, 2025:

---

| | | |
|:---|:---|:---|
|<br>(in thousands) | **April 30,**<br>**2025** | **January 31,**<br>**2025** |
| 2021 Notes | $315000 | $315000 |
| Revolving Credit Facility | 100000 | 100000 |
| Less: unamortized debt discounts and issuance costs | (1883) | (2247) |
| **Total debt** | **413117** | **412753** |
| Less: current maturities | 413117 | 100000 |
| &nbsp;&nbsp;&nbsp;**Long-term debt** | $**—** | $**312753** |

---

***2021 Notes***

On April 9, 2021, we issued $315.0 million in aggregate principal amount of 0.25% convertible senior notes due April 15, 2026 (the "2021 Notes"), unless earlier converted by the holders pursuant to their terms. The 2021 Notes are unsecured and pay interest in cash semiannually in arrears at a rate of 0.25% per annum.

We used a portion of the net proceeds from the issuance of the 2021 Notes to pay the costs of the Capped Calls described below. We also used a portion of the net proceeds from the issuance of the 2021 Notes, together with the net proceeds from the April 6, 2021 issuance of $200.0 million of Series B Preferred Stock, to repay a portion of the outstanding indebtedness under our Credit Agreement described below, to terminate an interest rate swap, and to repurchase shares of our common stock. The remainder is being used for working capital and other general corporate purposes.

The 2021 Notes are convertible into shares of our common stock at an initial conversion rate of 16.1092 shares per $1,000 principal amount of 2021 Notes, which represents an initial conversion price of approximately $62.08 per share, subject to adjustment upon the occurrence of certain events, and subject to customary anti-dilution adjustments. Prior to January 15, 2026, the 2021 Notes will be convertible only upon the occurrence of certain events and during certain periods, and will be convertible thereafter at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2021 Notes. Upon conversion of the 2021 Notes, holders will receive cash up to the aggregate principal amount, with any remainder to be settled with cash or common stock, or a combination thereof, at our election. As of April 30, 2025, the 2021 Notes were not convertible, and because their stated maturity was within 12 months of April 30, 2025 were included in debt, current on our condensed consolidated balance sheet. As of January 31, 2025, the 2021 Notes were included in long-term debt on our condensed consolidated balance sheet.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

We incurred approximately $8.9 million of issuance costs in connection with the 2021 Notes, which were deferred and are presented as a reduction of the current portion of long-term debt, and which are being amortized as interest expense over the term of the 2021 Notes. Including the impact of the deferred debt issuance costs, the effective interest rate on the 2021 Notes was approximately 0.83% at April 30, 2025.

Based on the closing market price of our common stock on April 30, 2025, the if-converted value of the 2021 Notes was less than their aggregate principal amount.

***Capped Calls***

In connection with the issuance of the 2021 Notes, on April 6, 2021 and April 8, 2021, we entered into capped call transactions (the "Capped Calls") with certain counterparties. The Capped Calls are generally intended to reduce the potential dilution to our common stock upon any conversion of the 2021 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2021 Notes, in the event that at the time of conversion our common stock price exceeds the conversion price, with such reduction and/or offset subject to a cap.

The Capped Calls exercise price is equal to the $62.08 initial conversion price of each of the 2021 Notes, and the cap price is $100.00, each subject to certain adjustments under the terms of the Capped Calls. Our exercise rights under the Capped Calls generally trigger upon conversion of the 2021 Notes, and the Capped Calls terminate upon maturity of the 2021 Notes, or the first day the 2021 Notes are no longer outstanding. As of April 30, 2025, no Capped Calls have been exercised.

Pursuant to their terms, the Capped Calls qualify for classification within stockholders' equity, and their fair value is not remeasured and adjusted as long as they continue to qualify for stockholders' equity classification. We paid approximately $41.1 million for the Capped Calls, including applicable transaction costs, which was recorded as a reduction to additional paid-in capital.

***Credit Agreement***

On June 29, 2017, we entered into a credit agreement with certain lenders and terminated a prior credit agreement. The credit agreement was amended in 2018, 2020, 2021, 2023, and 2025, as further described below (as amended, the "Credit Agreement").

The Credit Agreement initially was comprised of a $425.0 million term loan, and a $300.0 million revolving credit facility (the "Prior Revolving Credit Facility"). During the three months ended April 30, 2021, we repaid $309.0 million of our Term Loan, reducing the outstanding principal balance to $100.0 million. On April 27, 2023, we repaid the remaining $100.0 million outstanding principal balance on our Term Loan utilizing proceeds from borrowings under our Prior Revolving Credit Facility.

On March 25, 2025, we entered into an amendment to the Credit Agreement (the "Fifth Amendment"), which extended the expiration date of our revolving credit facility to March 25, 2030, subject to certain conditions as described below, and increased the aggregate borrowing commitments from $300.0 million to $500.0 million (the "Revolving Credit Facility"). As provided in the Fifth Amendment, the Revolving Credit Facility matures on March 25, 2030, provided that from and after January 7, 2026, the maturity date of the Revolving Credit Facility will be accelerated if we do not satisfy a minimum level of liquidity equal to (x) the principal amount outstanding under the 2021 Notes plus (y) $100.0 million (taking into account undrawn capacity under the expanded Revolving Credit Facility) at any time that more than $35.0 million in principal amount remains outstanding (and not cash collateralized) under the 2021 Notes.

Effective March 25, 2025, borrowings under the Credit Agreement bear interest, at our option, at either: (i) the ABR, plus the applicable margin therefor or (ii) Term Secured Overnight Financing Rate ("Term SOFR") plus the applicable margin. The applicable margin is determined based on our Leverage Ratio and ranges from 0.50% to 1.25% for ABR borrowings and from 1.50% to 2.25% for Term SOFR borrowings. Prior to the Fifth Amendment, the applicable margin ranged from 0.25% to 1.25% for ABR borrowings and from 1.25% to 2.25% for Term SOFR borrowings.

Borrowings outstanding under the Revolving Credit Facility were $100.0 million at April 30, 2025 and borrowings outstanding under the Prior Revolving Credit Facility were $100.0 million at January 31, 2025, which is included in debt, current on our condensed consolidated balance sheet. The applicable margin is determined by reference to our Consolidated Total Debt to Consolidated EBITDA (each as defined in the Credit Agreement) leverage ratio (the "Leverage Ratio"). As of April 30, 2025, the interest rate on our Revolving Credit Facility borrowings was 5.82%. In addition, we are required to pay a commitment fee with respect to unused availability under the Revolving Credit Facility at rates per annum determined by reference to our Leverage Ratio. The proceeds of borrowings under the Revolving Credit Facility may be used for working capital and general

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

corporate purposes, including for permitted acquisitions and permitted stock repurchases, and the repayment of existing debt such as the 2021 Notes.

Our obligations under the Credit Agreement are guaranteed by each of our direct and indirect existing and future material domestic wholly owned restricted subsidiaries, and are secured by a security interest in substantially all of our assets and the assets of the guarantor subsidiaries, subject to certain exceptions.

The Credit Agreement contains certain customary affirmative and negative covenants for credit facilities of this type. The Credit Agreement also contains a financial covenant that, solely with respect to the Revolving Credit Facility, requires us to maintain a Leverage Ratio of no greater than 4.50 to 1. The limitations imposed by the covenants are subject to certain exceptions as detailed in the Credit Agreement.

The Credit Agreement provides for events of default with corresponding grace periods that we believe are customary for credit facilities of this type. Upon an event of default, all of our obligations owed under the Credit Agreement may be declared immediately due and payable, and the lenders' commitments to make loans under the Credit Agreement may be terminated.

At the time of the Fifth Amendment, there were $0.5 million of unamortized deferred debt issuance costs associated with the Prior Revolving Credit Facility, of which $0.4 million were associated with commitments by lenders that are continuing to provide commitments under the Revolving Credit Facility and therefore continue to be deferred, and which are now being amortized over the term of the new Revolving Credit Facility. The remaining $0.1 million of unamortized deferred debt issuance costs associated with the Prior Revolving Credit Facility were expensed and are included within interest expense on our condensed consolidated statement of operations for the three months ended April 30, 2025. We also incurred $2.0 million of debt modification costs related to the Fifth Amendment, which have been deferred and are being amortized on a straight-line basis over the remaining term of the Revolving Credit Facility.

***Interest Expense***

The following table presents the components of interest expense incurred on the 2021 Notes and on borrowings under our Credit Agreement, for the three months ended April 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** |
|<br>(in thousands) | **2025** | **2024** |
| **2021 Notes:** |  |  |
| Interest expense at 0.25% coupon rate | $197 | $197 |
| Amortization of deferred debt issuance costs | 450 | 446 |
| &nbsp;&nbsp;&nbsp;**Total Interest Expense — 2021 Notes** | $**647** | $**643** |
| **Borrowings under Credit Agreement:** |  |  |
| Interest expense at contractual rates | $1521 | $1736 |
| Amortization of deferred debt issuance costs | 174 | 172 |
| Losses on early retirements of debt | 138 |  |
| &nbsp;&nbsp;&nbsp;**Total Interest Expense — Borrowings under Credit Agreement** | $**1833** | $**1908** |

---

***8.&nbsp;&nbsp;&nbsp;&nbsp;SUPPLEMENTAL CONDENSED CONSOLIDATED FINANCIAL STATEMENT INFORMATION***

***Condensed Consolidated Balance Sheets***

Inventories consisted of the following as of April 30, 2025 and January 31, 2025:

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

---

| | | |
|:---|:---|:---|
|<br>(in thousands) | **April 30,**<br>**2025** | **January 31,**<br>**2025** |
| Raw materials | $7160 | $5893 |
| Work-in-process | 183 | 208 |
| Finished goods | 7602 | 8210 |
| **Total inventories** | $**14945** | $**14311** |

---

Other liabilities consisted of the following as of April 30, 2025 and January 31, 2025:

---

| | | |
|:---|:---|:---|
|<br>(in thousands) | **April 30,**<br>**2025** | **January 31,**<br>**2025** |
| Unrecognized tax benefits, including interest and penalties | $68027 | $68469 |
| Other | 13084 | 22437 |
| &nbsp;&nbsp;**Total other liabilities** | $**81111** | $**90906** |

---

***Condensed Consolidated Statements of Operations***

Other income (expense), net consisted of the following for the three months ended April 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** |
|<br>(in thousands) | **2025** | **2024** |
| Foreign currency gains (losses), net | $723 | $(537) |
| Other, net | (227) | 39 |
| &nbsp;&nbsp;**Total other income (expense), net** | $**496** | $**(498)** |

---

***Condensed Consolidated Statements of Cash Flows***

The following table provides supplemental information regarding our condensed consolidated cash flows for the three months ended April 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** |
|<br>(in thousands) | **2025** | **2024** |
| Cash paid for interest | $1952 | $2210 |
| Cash payments of income taxes, net | $5341 | $6298 |
| Cash payments for operating leases | $2386 | $2037 |
| **Non-cash investing and financing transactions:** |  |  |
| Finance leases of property and equipment | $— | $634 |
| Accrued but unpaid purchases of property and equipment | $436 | $1081 |
| Accrued but unpaid purchases of treasury stock | $176 | $773 |
| Liabilities for contingent consideration in business combinations and asset acquisitions | $— | $3397 |
| Excise tax on share repurchases | $305 | $250 |

---

***9.&nbsp;&nbsp;&nbsp;&nbsp;CONVERTIBLE PREFERRED STOCK***

On December 4, 2019, we entered into the Investment Agreement with the Apax Investor whereby, subject to certain closing conditions, the Apax Investor agreed to make an investment in us in an amount up to $400.0 million as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• On May 7, 2020, we issued a total of 200,000 shares of our Series A Preferred Stock for an aggregate purchase price of $200.0 million, or $1,000 per share, to the Apax Investor. In connection therewith, we incurred direct and incremental costs of $2.7 million, including financial advisory fees, closing costs, legal fees, and other offering-related costs. These direct and incremental costs reduced the carrying amount of the Series A Preferred Stock.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In connection with the completion of the Spin-Off, on April 6, 2021, we issued a total of 200,000 shares of our Series B Preferred Stock for an aggregate purchase price of $200.0 million, or $1,000 per share, to the Apax Investor. In connection therewith, we incurred direct and incremental costs of $1.3 million, including financial advisory fees, closing costs, legal fees, and other offering-related costs. These direct and incremental costs reduced the carrying amount of the Series B Preferred Stock.

Each of the rights, preferences, and privileges of the Series A Preferred Stock and Series B Preferred Stock are set forth in separate certificates of designation filed with the Secretary of State of the State of Delaware on the applicable issuance date.

***Voting Rights***

Holders of the Preferred Stock have the right to vote on matters submitted to a vote of the holders of our common stock, on an as-converted basis; however, in no event will the holders of Preferred Stock have the right to vote shares of the Preferred Stock on an as-converted basis in excess of 19.9% of the voting power of the common stock outstanding immediately prior to December 4, 2019.

***Dividends and Liquidation Rights***

The Preferred Stock ranks senior to the shares of our common stock with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of our affairs. Shares of Preferred Stock have a liquidation preference of the greater of $1,000 per share or the amount that would be received if the shares are converted at the then applicable conversion price at the time of such liquidation.

Each series of Preferred Stock paid dividends at an annual rate of 5.2% until May 7, 2024, and thereafter pays at a rate of 4.0%, subject to adjustment under certain circumstances. Dividends on the Preferred Stock are cumulative and payable semi-annually in arrears in cash. All dividends that are not paid in cash will remain accumulated dividends with respect to each share of Preferred Stock. The dividend rate is subject to increase (i) to 6.0% per annum in the event the number of shares of common stock into which the Preferred Stock could be converted exceeds 19.9% of the voting power of outstanding common stock on December 4, 2019 (unless we obtain shareholder approval of the issuance of common stock upon conversion of the Preferred Stock) and (ii) by 1.0% each year, up to a maximum dividend rate of 10.0% per annum, in the event we fail to satisfy our obligations to redeem the Preferred Stock in specified circumstances.

For the three months ended April 30, 2025, we paid $8.0 million of preferred stock dividends, all of which was accrued as of January 31, 2025, and there were $5.3 million of cumulative undeclared and unpaid preferred stock dividends at April 30, 2025. There were no accrued dividends as of April 30, 2025. We reflected $4.0 million and $5.2 million of preferred stock dividends in our condensed consolidated results of operations, for purposes of computing net (loss) income attributable to Verint Systems Inc. common shares, for the three months ended April 30, 2025 and 2024, respectively.

***Conversion***

The Series A Preferred Stock was initially convertible into common stock at the election of the holder, subject to certain conditions, at an initial conversion price of $53.50 per share. The initial conversion price represented a conversion premium of 17.1% over the volume-weighted average price per share of our common stock over the 45 consecutive trading days immediately prior to December 4, 2019. In accordance with the Investment Agreement, the Series A Preferred Stock did not participate in the Spin-Off distribution of the Cognyte shares, which occurred on February 1, 2021, and the Series A Preferred Stock conversion price was instead adjusted to $36.38 per share based on the ratio of the relative trading prices of Verint and Cognyte following the Spin-Off.

The Series B Preferred Stock is convertible at a conversion price of $50.25, based in part on our trading price over the 20-day trading period following the Spin-Off.

As of April 30, 2025, the maximum number of shares of common stock that could be required to be issued upon conversion of the outstanding shares of Preferred Stock was approximately 9.6 million shares and Apax's ownership in us on an as-converted basis was approximately 13.7%.

Beginning May 7, 2023, in the case of the Series A Preferred Stock, and April 6, 2024, in the case of the Series B Preferred Stock, we have the option to require that all (but not less than all) of the then-outstanding shares of Preferred Stock of the series convert into common stock if the volume-weighted average price per share of the common stock for at least 30 trading days in any 45 consecutive trading day period exceeds 175% of the then-applicable conversion price of such series (a "Mandatory

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

Conversion"). As of April 30, 2025, the volume-weighted average price per share of common stock has not exceeded 175% of the $36.38 conversion price of the Series A Preferred Stock or the $50.25 conversion price of the Series B Preferred Stock.

We may redeem any or all of the Preferred Stock of a series for cash at any time after May 7, 2026, in the case of the Series A Preferred Stock, and April 6, 2027, in the case of the Series B Preferred Stock, at a redemption price equal to 100% of the liquidation preference of the shares of the Preferred Stock, plus any accrued and unpaid dividends to, but excluding, the redemption date, plus a make-whole amount designed to allow the Apax Investor to earn a total 8.0% internal rate of return on such shares.

The Preferred Stock may not be sold or transferred without our prior written consent. The common stock issuable upon conversion of the Preferred Stock is not subject to this restriction. The restriction on the sale or transfer of the Preferred Stock does not apply to certain transfers to one or more permitted co-investors or transfers or pledges of the Preferred Stock pursuant to the terms of specified margin loans entered into by the Apax Investor as well as transfers effected pursuant to a merger, consolidation, or similar transaction consummated by us and transfers that are approved by our board of directors.

At any time after November 7, 2028, in the case of the Series A Preferred Stock, and October 6, 2029, in the case of the Series B Preferred Stock, or upon the occurrence of a change of control triggering event (as defined in the certificates of designation), the holders of the applicable series of Preferred Stock will have the right to cause us to redeem all of the outstanding shares of Preferred Stock for cash at a redemption price equal to 100% of the liquidation preference of the shares of such series, plus any accrued and unpaid dividends to, but excluding, the redemption date. Therefore, the Preferred Stock has been classified as temporary equity on our condensed consolidated balance sheets as of April 30, 2025 and January 31, 2025, separate from permanent equity, as the potential required repurchase of the Preferred Stock, however remote in likelihood, is not solely under our control.

As of April 30, 2025, the Preferred Stock was not redeemable, and we have concluded that it is currently not probable of becoming redeemable, including from the occurrence of a change in control triggering event. The holders' redemption rights which occur at November 7, 2028, in the case of the Series A Preferred Stock, and October 6, 2029, in the case of the Series B Preferred Stock, are not considered probable because there is a more than remote likelihood that the Mandatory Conversion may occur prior to such redemption rights. We therefore did not adjust the carrying amount of the Preferred Stock to its current redemption amount, which was its liquidation preference at April 30, 2025 plus accrued and unpaid dividends. As of April 30, 2025, the stated value of the liquidation preference for each series of Preferred Stock was $200.0 million and cumulative, unpaid dividends on each series of Preferred Stock was $2.7 million.

***Future Tranche Right***

We determined that our obligation to issue and the Apax Investor's obligation to purchase 200,000 shares of the Series B Preferred Stock in connection with the completion of the Spin-Off and the satisfaction of other customary closing conditions (the "Future Tranche Right") met the definition of a freestanding financial instrument as the Future Tranche Right was legally detachable and separately exercisable from the Series A Preferred Stock. At issuance, we allocated a portion of the proceeds from the issuance of the Series A Preferred Stock to the Future Tranche Right based upon its fair value at such time, with the remaining proceeds being allocated to the Series A Preferred Stock. The Future Tranche Right was remeasured at fair value each reporting period until the settlement of the right (at the time of the issuance of the Series B Preferred Stock), and changes in its fair value were recognized as a non-cash charge or benefit within other income (expense), net on the condensed consolidated statements of operations.

Upon issuance of the Series A Preferred Stock on May 7, 2020, the Future Tranche Right was recorded as an asset of $3.4 million, as the purchase price of the Series B Preferred Stock was greater than its estimated fair value at the expected settlement date. This resulted in a $203.4 million carrying value, before direct and incremental issuance costs, for the Series A Preferred Stock.

Immediately prior to the issuance of the Series B Preferred Stock, the Future Tranche Right was remeasured and upon the issuance of the Series B Preferred Stock in April 2021, the Future Tranche Right was settled, resulting in a reclassification of the $37.0 million fair value of the Future Tranche Right liability at that time to the carrying value of the Series B Preferred Stock. This resulted in a $237.0 million carrying value, before direct and incremental issuance costs, for the Series B Preferred Stock. As a result of the issuance of the Series B Preferred Stock, we no longer recognize changes in the fair value of the Future Tranche Right in our condensed consolidated statements of operations.

***10.&nbsp;&nbsp;&nbsp;&nbsp;STOCKHOLDERS' EQUITY***

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

***Common Stock Dividends***

We did not declare or pay any cash dividends on our common stock during the three months ended April 30, 2025 and 2024. Under the terms of our Credit Agreement, we are subject to certain restrictions on declaring and paying cash dividends on our common stock.

***Treasury Stock***

From time to time, our board of directors has approved limited programs to repurchase shares of our common stock from our directors or officers in connection with the vesting of restricted stock or restricted performance stock units to facilitate required income tax withholding by us or the payment of required incomes taxes by such holders. In addition, the terms of some of our equity award agreements with all grantees provide for automatic repurchases by us for the same purpose if a vesting-related or delivery-related tax event occurs at a time when the holder is not permitted to sell shares in the market. Our stock bonus program contains similar terms. Any such repurchases of common stock occur at prevailing market prices and are recorded as treasury stock.

When treasury shares are reissued, they are recorded at the average cost of the treasury shares acquired.

No treasury stock remained outstanding at April 30, 2025 and January 31, 2025, respectively.

***Stock Repurchase Programs***

On September 4, 2024, we announced that our board of directors had authorized a new stock repurchase program for the period from August 29, 2024 until August 29, 2026, whereby we may repurchase shares of common stock not to exceed, in the aggregate, $200.0 million.

On December 7, 2022, we announced that our board of directors had authorized a stock repurchase program for the period from December 12, 2022 until January 31, 2025, whereby we may repurchase shares of common stock in an amount not to exceed, in the aggregate, $200.0 million during, which was completed during the six months ended July 31, 2024.

During the three months ended April 30, 2025, we repurchased approximately 2,449,000 shares of common stock for a cost of $40.7 million under the new stock repurchase program, with $0.2 million of these repurchases settled in cash in early May 2025. In addition, approximately 83,000 shares were repurchased to facilitate income tax withholding or payments as described above for a cost of $1.3 million. Our share repurchases in excess of issuances are subject to a 1% excise tax enacted by the Inflation Reduction Act ("IRA"). We recognized excise tax of $0.3 million as part of the cost basis of shares acquired in the condensed consolidated statements of stockholders' equity during the three months ended April 30, 2025. We retired all 2,532,000 shares, reducing common stock and additional paid-in capital, and returned the shares to the status of authorized and unissued share capital.

During the three months ended April 30, 2024, we repurchased and retired 1,234,000 shares of our common stock for a cost of $38.1 million, including excise tax of $0.3 million.

***Issuance of Convertible Preferred Stock***

On December 4, 2019, in conjunction with the planned Spin-Off, we announced that an affiliate of Apax Partners would invest up to $400.0 million in us, in the form of convertible preferred stock. Under the terms of the Investment Agreement, the Apax Investor purchased $200.0 million of our Series A Preferred Stock, which closed on May 7, 2020. In connection with the completion of the Spin-Off, the Apax Investor purchased $200.0 million of our Series B Preferred Stock, which closed on April 6, 2021. As of April 30, 2025, Apax's ownership in us on an as-converted basis was approximately 13.7%. Please refer to Note 9, "Convertible Preferred Stock" for a more detailed discussion of the Apax investment.

***Accumulated Other Comprehensive Loss***

Accumulated other comprehensive loss includes items such as foreign currency translation adjustments and unrealized gains and losses on derivative financial instruments designated as hedges. Accumulated other comprehensive loss is presented as a separate line item in the stockholders' equity section of our condensed consolidated balance sheets. Accumulated other comprehensive loss items have no impact on our net (loss) income as presented in our condensed consolidated statements of operations.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

The following table summarizes changes in the components of our accumulated other comprehensive loss by component for the three months ended April 30, 2025:

---

| | | | |
|:---|:---|:---|:---|
| (in thousands) | **Unrealized Gains (Losses) on Foreign Exchange Contracts Designated as Hedges** | **Foreign Currency Translation Adjustments** | **Total** |
| **Accumulated other comprehensive income (loss) at January 31, 2025** | $**117** | $**(153056)** | $**(152939)** |
| Other comprehensive (loss) income before reclassifications | (86) | 34219 | 34133 |
| Amounts reclassified out of accumulated other comprehensive income (loss) | 11 |  | 11 |
| Net other comprehensive (loss) income | (97) | 34219 | 34122 |
| **Accumulated other comprehensive income (loss) at April 30, 2025** | $**20** | $**(118837)** | $**(118817)** |

---

All amounts presented in the table above are net of income taxes, if applicable. The accumulated net losses in foreign currency translation adjustments primarily reflect the strengthening of the U.S. dollar against the British pound sterling, which has resulted in lower U.S. dollar-translated balances of British pound sterling-denominated goodwill and intangible assets.

The amounts reclassified out of accumulated other comprehensive loss into the condensed consolidated statements of operations were not material for the three months ended April 30, 2025 and 2024.

***11. INCOME TAXES***

Our interim provision for income taxes is measured using an estimated annual effective income tax rate, adjusted for discrete items that occur within the periods presented.

For the three months ended April 30, 2025, we recorded an income tax provision of $2.6 million on pretax income of $4.5 million, which represented an effective income tax rate of 57.5%. The effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to the U.S. taxation of certain foreign activities and the income tax impacts of stock-based compensation, offset by the benefit of certain domestic tax credits and lower statutory rates in certain foreign jurisdictions.

For the three months ended April 30, 2024, we recorded an income tax provision of $8.0 million on pretax income of $23.3 million, which represented an effective income tax rate of 34.1%. The effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to the U.S. taxation of certain foreign activities, offset by lower statutory rates in certain foreign jurisdictions.

We evaluate the realizability of deferred income tax assets on a jurisdictional basis at each reporting date. A valuation allowance is established when it is more-likely-than-not that all or a portion of the deferred income tax assets will not be realized. In circumstances where there is sufficient negative evidence indicating that the deferred income tax assets are not more-likely-than-not realizable, we establish a valuation allowance. We determined that there is sufficient negative evidence to maintain the valuation allowances against certain state and foreign deferred income tax assets as a result of historical losses in the most recent three-year period in certain state and foreign jurisdictions. We intend to maintain valuation allowances until sufficient positive evidence exists to support a reversal.

We had unrecognized income tax benefits of $75.5 million and $75.9 million (excluding interest and penalties) as of April 30, 2025 and January 31, 2025, respectively, that if recognized, would impact our effective income tax rate. The accrued liability for interest and penalties was $9.0 million and $8.9 million at April 30, 2025 and January 31, 2025, respectively. Interest and penalties are recorded as a component of the provision for income taxes in our condensed consolidated statements of operations. We regularly assess the adequacy of our provisions for income tax contingencies in accordance with the applicable authoritative guidance on accounting for income taxes. As a result, we may adjust the reserves for unrecognized income tax benefits for the impact of new facts and developments, such as changes to interpretations of relevant tax law, assessments from taxing authorities, settlements with taxing authorities, and lapses of statutes of limitation. Our income tax returns are subject to ongoing tax examinations in several jurisdictions in which we operate. We also believe that it is reasonably possible that new

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

issues may be raised by tax authorities or developments in tax audits may occur, which would require increases or decreases to the balance of reserves for unrecognized income tax benefits; however, an estimate of such changes cannot reasonably be made.

The Organization for Economic Co-operation and Development ("OECD") Pillar 2 guidelines address the increasing digitalization of the global economy, re-allocating taxing rights among countries. The European Union and many other member states have committed to adopting Pillar 2 which calls for a global minimum tax of 15% to be effective for tax years beginning in 2024. Certain jurisdictions in which we operate have enacted Pillar 2 legislation and others are considering changes to their tax laws to adopt the Pillar 2 proposals. We continue to monitor developments and evaluate the impacts of new rules as they are published, including eligibility to qualify for safe harbor rules. Pillar 2 did not have a material impact on our income tax expense for the three months ended April 30, 2025 and 2024.

***12. FAIR VALUE MEASUREMENTS***

***Assets and Liabilities Measured at Fair Value on a Recurring Basis***

Our assets and liabilities measured at fair value on a recurring basis consisted of the following as of April 30, 2025 and January 31, 2025:

---

| | | | |
|:---|:---|:---|:---|
| | **April 30, 2025** | **April 30, 2025** | **April 30, 2025** |
| | **Fair Value Hierarchy Category** | **Fair Value Hierarchy Category** | **Fair Value Hierarchy Category** |
|<br>(in thousands) | **Level 1** | **Level 2** | **Level 3** |
| **Assets:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Money market funds | $28483 | $— | $— |
| &nbsp;&nbsp;&nbsp;U.S. Treasury bills, classified as cash and cash equivalents | 249 |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency forward contracts |  | 57 |  |
| &nbsp;&nbsp;&nbsp;Contingent consideration receivable | **—** | **—** | 2215 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total assets** | $**28732** | $**57** | $**2215** |
| **Liabilities:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency forward contracts | $— | $32 | $— |
| &nbsp;&nbsp;&nbsp;Contingent consideration — business combinations |  |  | 8159 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities** | $**—** | $**32** | $**8159** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **January 31, 2025** | **January 31, 2025** | **January 31, 2025** |
| | **Fair Value Hierarchy Category** | **Fair Value Hierarchy Category** | **Fair Value Hierarchy Category** |
|<br>(in thousands) | **Level 1** | **Level 2** | **Level 3** |
| **Assets:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Money market funds | $56019 | $— | $— |
| &nbsp;&nbsp;&nbsp;Foreign currency forward contracts |  | 141 |  |
| &nbsp;&nbsp;&nbsp;Contingent consideration receivable |  |  | 2951 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total assets** | $**56019** | $**141** | $**2951** |
| **Liabilities:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Contingent consideration — business combinations |  |  | 22046 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities** | $**—** | $**—** | $**22046** |

---

On January 31, 2024, we completed the sale of a service business for manual quality managed services for no upfront cash consideration, with an estimated valuation of $6.0 million based on (i) the estimated fair value of our share of the future adjusted operating income (as defined in the agreement) of the business, to be paid annually over a minimum of six years following the transaction closing date, (ii) the amount by which the closing working capital of the business exceeds the working capital target, and (iii) the estimated amount of future collections of outstanding receivables as of the closing date from a certain customer, net of certain expenses. We engaged a third-party to assist in valuing the contingent consideration, which was valued at $2.2 million as of April 30, 2025, and is included within other assets on our condensed consolidated balance sheets. During the three months ended April 30, 2025 and 2024, we received no contingent consideration payments and recorded charges of $0.7 million and 0.3 million, respectively, for changes in the estimated fair value of this contingent receivable.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

The following table presents the changes in the estimated fair values of our liabilities for contingent consideration measured using significant unobservable inputs (Level 3) for the three months ended April 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** |
|<br>(in thousands) | **2025** | **2024** |
| Fair value measurement at beginning of period | $22046 | $3511 |
| Contingent consideration liabilities recorded for business combinations |  | 3397 |
| Changes in fair values, recorded in operating expenses | (7696) | (433) |
| Payments of contingent consideration | (6388) | (277) |
| Foreign currency translation and other | 197 | (16) |
| **Fair value measurement at end of period** | $**8159** | $**6182** |

---

Our estimated liability for contingent consideration represents potential payments of additional consideration for business combinations, payable if certain defined performance goals are achieved. Changes in fair value of contingent consideration are recorded in the condensed consolidated statements of operations within selling, general and administrative expenses.

There were no transfers between levels of the fair value measurement hierarchy during the three months ended April 30, 2025 and 2024.

***Fair Value Measurements***

*Money Market Funds and U.S. Treasury Bills* — We value our money market funds and U.S. treasury bills using quoted active market prices for such instruments.

*Short-term Investments, Corporate Debt Securities, and Commercial Paper —* The fair values of short-term investments, as well as corporate debt securities and commercial paper classified as cash equivalents, are estimated using observable market prices for identical securities that are traded in less-active markets, if available. When observable market prices for identical securities are not available, we value these short-term investments using non-binding market price quotes from brokers which we review for reasonableness using observable market data; quoted market prices for similar instruments; or pricing models, such as a discounted cash flow model.

*Foreign Currency Forward Contracts* — The estimated fair value of foreign currency forward contracts is based on quotes received from the counterparties thereto. These quotes are reviewed for reasonableness by discounting the future estimated cash flows under the contracts, considering the terms and maturities of the contracts and market foreign currency exchange rates using readily observable market prices for similar contracts.

*Contingent Consideration Assets and Liabilities — Business Combinations and Divestitures* — The fair value of the contingent consideration related to business combinations and divestitures is estimated using a probability-adjusted discounted cash flow model. These fair value measurements are based on significant inputs not observable in the market. The key internally developed assumptions used in these models are discount rates and the probabilities assigned to the milestones to be achieved. We remeasure the fair value of the contingent consideration at each reporting period, and any changes in fair value resulting from either the passage of time or events occurring after the acquisition date, such as changes in discount rates, or in the expectations of achieving the performance targets, are recorded within selling, general, and administrative expenses. Increases or decreases in discount rates would have inverse impacts on the related fair value measurements, while favorable or unfavorable changes in expectations of achieving performance targets would result in corresponding increases or decreases in the related fair value measurements. As of April 30, 2025, we utilized discount rates ranging from 4.2% to 7.8%, with a weighted average discount rate of 5.9% for our contingent consideration liabilities and 6.9% to 11.0%, with a weighted average discount rate of 8.7% for our contingent consideration asset. As of January 31, 2025, we utilized discount rates ranging from 4.5% to 6.2%, with a weighted average discount rate of 5.8% for our contingent consideration liabilities and 6.7% to 8.6%, with a weighted average discount rate of 7.4% for our contingent consideration asset.

***Other Financial Instruments***

The carrying amounts of accounts receivable, contract assets, accounts payable, and accrued liabilities and other current liabilities approximate fair value due to their short maturities.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

The estimated fair value of our Revolving Credit Facility borrowing was approximately $99.0 million at April 30, 2025 and the estimated fair value of our Prior Revolving Facility borrowing was approximately $99.0 million at January 31, 2025. The estimated fair value of borrowings under our Revolving Credit Facility and Prior Revolving Credit Facility, as applicable, is based upon indicative market values provided by one of our lenders. The indicative prices provided to us at April 30, 2025 and January 31, 2025 did not significantly differ from par value.

The estimated fair values of our 2021 Notes were approximately $300.0 million and $298.0 million at April 30, 2025 and January 31, 2025, respectively. The estimated fair values of the 2021 Notes were determined based on quoted bid and ask prices in the over-the-counter market in which the 2021 Notes traded. We consider these inputs to be within Level 2 of the fair value hierarchy.

***Assets and Liabilities Not Measured at Fair Value on a Recurring Basis***

In addition to assets and liabilities that are measured at fair value on a recurring basis, we also measure certain assets and liabilities at fair value on a nonrecurring basis. Our non-financial assets, including goodwill, intangible assets, operating lease right-of-use assets, and property, plant and equipment, are measured at fair value when there is an indication of impairment and the carrying amount exceeds the asset's projected undiscounted cash flows. These assets are recorded at fair value only when an impairment charge is recognized.

*Investments*

During the three months ended April 30, 2024, we completed the acquisition of a privately-held company in which we previously held a SAFE investment of approximately $1.7 million. The SAFE agreement entitled us to receive shares upon the company's qualified equity financing, calculated by dividing the SAFE purchase amount by the Discount Price (as such term is defined in the SAFE), or in a liquidity event, a cash payment equal to the greater of (a) the SAFE purchase amount or (b) the amount payable on the number of shares valued at the Liquidity Price (as such term is defined in the SAFE). The investment was carried at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer and was included within other assets on the consolidated balance sheets as of January 31, 2024. The approximately $1.7 million acquisition date fair value of the SAFE was included in the measurement of the consideration transferred. The company and its results of operations are now consolidated in our condensed consolidated financial statements, and the SAFE investment was removed from our condensed consolidated balance sheet as of April 30, 2024. Please refer to Note 5, "Business Combinations and Asset Acquisitions" for further discussion related to this acquisition.

The carrying amount of our noncontrolling equity investments in privately-held companies without readily determinable fair values was $4.7 million as of April 30, 2025 and January 31, 2025. These investments are included within other assets on the condensed consolidated balance sheets. There were no observable price changes in our investments in privately-held companies during the three months ended April 30, 2025 and 2024. We did not recognize any impairments during the three months ended April 30, 2025 and 2024.

***13. DERIVATIVE FINANCIAL INSTRUMENTS***

Our primary objective for holding derivative financial instruments is to manage foreign currency exchange rate risk and interest rate risk, when deemed appropriate. We enter into these contracts in the normal course of business to mitigate risks and not for speculative purposes.

***Foreign Currency Forward Contracts***

Under our risk management strategy, we periodically use foreign currency forward contracts to manage our short-term exposures to fluctuations in operational cash flows resulting from changes in foreign currency exchange rates. These cash flow exposures result from portions of our forecasted operating expenses, primarily compensation and related expenses, which are transacted in currencies other than the U.S. dollar, most notably the Israeli shekel. We also periodically utilize foreign currency forward contracts to manage exposures resulting from forecasted customer collections to be remitted in currencies other than the applicable functional currency, and exposures from cash, cash equivalents and short-term investments denominated in currencies other than the applicable functional currency. These foreign currency forward contracts generally have maturities of no longer than twelve months, although occasionally we will execute a contract that extends beyond twelve months, depending upon the nature of the underlying risk.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

We held outstanding foreign currency forward contracts with notional amounts of $6.4 million as of April 30, 2025 and January 31, 2025.

***Fair Values of Derivative Financial Instruments***

The fair values of our derivative financial instruments were not material as of April 30, 2025 and January 31, 2025.

***Derivative Financial Instruments in Cash Flow Hedging Relationships***

The effects of derivative financial instruments designated as cash flow hedges on accumulated other comprehensive loss ("AOCL") and on the condensed consolidated statement of operations for the three months ended April 30, 2025 and 2024 were as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** |
|<br>(in thousands) | **2025** | **2024** |
| **Net losses recognized in AOCL:** |  |  |
| Foreign currency forward contracts | $(103) | $(233) |
| **Net gains reclassified from AOCL to the condensed consolidated statements of operations:** |  |  |
| Foreign currency forward contracts | $13 | $33 |

---

All of the foreign currency forward contracts underlying the net unrealized losses recorded in our accumulated other comprehensive loss at April 30, 2025 mature within twelve months, and therefore we expect all such losses to be reclassified into earnings within the next twelve months.

***14. STOCK-BASED COMPENSATION***

***Stock-Based Compensation Plan***

On June 22, 2023, our stockholders approved the Verint Systems Inc. 2023 Long-Term Stock Incentive Plan (the "2023 Plan"). Upon approval of the 2023 Plan, new awards were no longer permitted under our prior stock-based compensation plan (the "2019 Plan"). Awards outstanding at June 22, 2023 under the 2019 Plan or other previous stock-based compensation plans were not impacted by the approval of the 2023 Plan. Collectively, our stock-based compensation plans are referred to herein as the "Plans".

The 2023 Plan authorizes our board of directors to provide equity-based compensation in the form of stock options, stock appreciation rights, restricted stock, restricted stock units ("RSUs"), performance awards, other stock-based awards, and performance compensation awards. Subject to adjustment as provided in the 2023 Plan, up to an aggregate of (i) 9,000,000 shares of our common stock plus (ii) 3,982,168 shares of our common stock available for issuance under the 2019 Plan as of June 22, 2023, plus (iii) the number of shares of our common stock that become available for issuance as a result of awards made under the 2019 Plan or the 2023 Plan that are forfeited, cancelled, exchanged, or that terminate or expire, may be issued or transferred in connection with awards under the 2023 Plan. Each stock option or stock-settled stock appreciation right granted under the 2023 Plan will reduce the available plan capacity by one share and each other award denominated in shares that is granted under the 2023 Plan will reduce the available plan capacity by 1.9 shares.

At our annual meeting of stockholders on June 19, 2025, our stockholders will be asked to consider a proposal to approve Amendment No. 1 to the 2023 Plan. The amendment, if approved, will increase the number of shares available for issuance under the 2023 Plan, adjust the fungibility ratio, and extend the expiration date of the 2023 Plan.

***Stock-Based Compensation Expense***

We recognized stock-based compensation expense in the following line items on the condensed consolidated statements of operations for the three months ended April 30, 2025 and 2024:

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** |
|<br>(in thousands) | **2025** | **2024** |
| Cost of revenue — recurring | $445 | $549 |
| Cost of revenue — nonrecurring perpetual | 22 | 14 |
| Cost of revenue — nonrecurring professional services and other | (146) | 519 |
| Research and development, net | 3093 | 3543 |
| Selling, general and administrative | 12053 | 13396 |
| &nbsp;&nbsp;&nbsp;**Total stock-based compensation expense** | $**15467** | $**18021** |

---

The following table summarizes stock-based compensation expense by type of award for the three months ended April 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** |
|<br>(in thousands) | **2025** | **2024** |
| Restricted stock units and restricted stock awards | $13540 | $16508 |
| Stock bonus program and bonus share program | 1888 | 1501 |
| **Total equity-settled awards** | **15428** | **18009** |
| Phantom stock units (cash-settled awards) | 39 | 12 |
| &nbsp;&nbsp;&nbsp;**Total stock-based compensation expense** | $**15467** | $**18021** |

---

Awards are generally subject to multi-year vesting periods. We recognize compensation expense for awards on a straight-line basis over the requisite service periods of the awards, which are generally the vesting periods, reduced by estimated forfeitures.

Awards under our stock bonus and bonus share programs are accounted for as liability-classified awards, because the obligations are based predominantly on fixed monetary amounts that are generally known at inception of the obligation, to be settled with a variable number of shares of our common stock, which for a portion of the awards under our stock bonus program is determined using a discounted average price of our common stock.

***Restricted Stock Units and Performance Stock Units***

We periodically award RSUs to our directors, officers, and other employees. These awards contain various vesting conditions and are subject to certain restrictions and forfeiture provisions prior to vesting. Some of these awards to executive officers and certain other employees vest upon the achievement of specified performance goals or market conditions (performance stock units or "PSUs").

The following table ("Award Activity Table") summarizes activity for RSUs, PSUs, and other stock awards that reduce available Plan capacity under the Plans for the three months ended April 30, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended April 30,** | **Three Months Ended April 30,** | **Three Months Ended April 30,** | **Three Months Ended April 30,** |
| | **2025** | **2025** | **2024** | **2024** |
|<br>(in thousands, except grant date fair values) | **Shares or Units** | **Weighted-Average Grant Date Fair Value** | **Shares or Units** | **Weighted-Average Grant Date Fair Value** |
| Beginning balance | 3182 | $33.64 | 2658 | $43.29 |
| Granted | 2799 | $16.35 | 2261 | $29.56 |
| Released | (642) | $36.81 | (410) | $52.28 |
| Forfeited | (164) | $51.45 | (111) | $55.71 |
| &nbsp;&nbsp;&nbsp;**Ending balance** | **5175** | $**23.33** | **4398** | $**35.08** |

---

With respect to our stock bonus program, the activity presented in the table above only includes shares earned and released in consideration of the discount provided under that program. Consistent with the provisions of the Plans under which such shares are issued, other shares issued under the stock bonus program are not included in the table above because they do not reduce available plan capacity (since such shares are deemed to be purchased by the grantee at fair value in lieu of receiving an earned

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

cash bonus). Activity presented in the table above includes all shares awarded and released under the bonus share program. Further details appear below under "Stock Bonus Program and Bonus Share Program".

Our RSU and PSU awards may include a provision which allows the awards to be settled with cash payments upon vesting, rather than with delivery of common stock, at the discretion of our board of directors. As of April 30, 2025, for such awards that are outstanding, settlement with cash payments was not considered probable, and therefore these awards have been accounted for as equity-classified awards and are included in the table above.

The following table summarizes PSU activity in isolation under the Plans for the three months ended April 30, 2025 and 2024 (these amounts are also included in the Award Activity Table above for 2025 and 2024):

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** |
|<br>(in thousands) | **2025** | **2024** |
| Beginning balance | 645 | 532 |
| Granted | 471 | 358 |
| Released | (130) | (160) |
| Forfeited | (100) | (81) |
| &nbsp;&nbsp;&nbsp;**Ending balance** | **886** | **649** |

---

Excluding PSUs, we granted 2,328,000 RSUs during the three months ended April 30, 2025.

As of April 30, 2025, there was approximately $97.2 million of total unrecognized compensation expense, net of estimated forfeitures, related to unvested RSUs, which is expected to be recognized over a weighted-average period of 2.4 years.

***Stock Bonus Program and Bonus Share Program***

Our stock bonus program permits eligible employees to receive a portion of their earned bonuses, otherwise payable in cash, in the form of discounted shares of our common stock. Executive officers are eligible to participate in this program to the extent that capacity remains available under the program following the enrollment of all other participants. Shares awarded to executive officers with respect to the discount feature of the program are subject to a one-year vesting period. This program is subject to annual funding approval by our board of directors and an annual cap on the number of shares that can be issued. Subject to these limitations, the number of shares to be issued under the program for a given year is determined using a five-day trailing average price of our common stock when the awards are calculated, reduced by a discount determined by the board of directors each year (the "discount"). To the extent that this program is not funded in a given year or the number of shares of common stock needed to fully satisfy employee enrollment exceeds the annual cap, the applicable portion of the employee bonuses will generally revert to being paid in cash.

Under our bonus share program, we may provide discretionary bonuses to employees or pay earned bonuses that are outside the stock bonus program in the form of shares of common stock. Unlike the stock bonus program, there is no enrollment for this program and no discount feature.

For bonuses in respect of the year ended January 31, 2025, our board of directors approved the use of up to 400,000 shares of common stock in the aggregate for awards under these two programs, with up to 200,000 of these shares of common stock and a discount of 15% approved for awards under our stock bonus program. We currently expect to issue approximately 400,000 shares under the bonus share program, in respect of the year ended January 31, 2025, during the first half of the year ending January 31, 2026. The stock bonus program was not used, and no shares will be issued under this program, in respect of the performance period ended January 31, 2025.

In March 2025, our board of directors approved the use of up to 400,000 shares of common stock in the aggregate under these two programs, with up to 200,000 of these shares of common stock and a discount of 15%, for awards under our stock bonus program for the performance period ending January 31, 2026. Any shares earned under these programs will be issued during the year ending January 31, 2027.

The combined accrued liabilities for these two programs were $11.6 million and $9.7 million at April 30, 2025 and January 31, 2025, respectively.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

***15. COMMITMENTS AND CONTINGENCIES***

***Legal Proceedings***

We are a party to various litigation matters and claims that arise from time to time in the ordinary course of business. Based on information currently available, we do not believe that any such current legal proceedings, individually or in the aggregate, will have a material adverse effect on our financial condition, results of operations, or liquidity. However, the litigation process is inherently uncertain, and we cannot guarantee a favorable outcome for any matter.

We record litigation accruals for legal matters which are both probable and estimable. For legal proceedings for which there is reasonable possibility of loss (meaning those losses for which the likelihood is more than remote but less than probable), we have determined we do not have a material exposure, either individually or in the aggregate.

***16.SEGMENT INFORMATION***

***Segment Information***

Operating segments are defined as components of an enterprise for which discrete financial information is available that is

evaluated regularly by the enterprise's chief operating decision maker, or CODM, or decision making group, in deciding how to allocate resources and in assessing performance. Our Chief Executive Officer is our CODM.

We are a pure-play customer engagement company that operates as a single operating and reporting segment as our CODM reviews the financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Our CODM decides how to allocate resources based on consolidated net income (loss) as shown in our condensed consolidated statement of operations as net income (loss). The measure of segment assets that is reviewed by the CODM is reported on the condensed consolidated balance sheet as total assets. The CODM uses consolidated net income to assess the profitability of the business, in the annual forecasting process, and to monitor period-over-period results to assess performance and make decisions about allocating resources.

The significant expense categories and consolidated net income details provided to the CODM for the three months ended April 30, 2025 and 2024 were as follows:

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

---

| | | |
|:---|:---|:---|
| | **Three Months Ended <br>April 30,** | **Three Months Ended <br>April 30,** |
|<br>(in thousands) | **2025** | **2024** |
| **Recurring revenue:** |  |  |
| Bundled SaaS revenue | $81257 | $65695 |
| Unbundled SaaS revenue | 66227 | 75288 |
| &nbsp;&nbsp;**Total SaaS revenue** | **147484** | **140983** |
| Optional managed services revenue | 5014 | 5168 |
| Support revenue | 21125 | 27377 |
| &nbsp;&nbsp;**Total recurring revenue** | **173623** | **173528** |
| **Nonrecurring perpetual revenue** | **17021** | **24900** |
| **Nonrecurring professional services and other revenue** | **17453** | **22849** |
| &nbsp;&nbsp;**Total revenue** | **208097** | **221277** |
| **Less:** |  |  |
| Cost of recurring revenue | 42108 | 35923 |
| Cost of nonrecurring perpetual revenue | 7248 | 8774 |
| Cost of nonrecurring professional services and other revenue | 17531 | 17706 |
| Amortization of acquired technology | 2308 | 1358 |
| &nbsp;&nbsp;**Total cost of revenue** | **69195** | **63761** |
| **Less:** |  |  |
| Employee compensation and related expenses | 94317 | 88959 |
| Stock-based compensation expense | 15146 | 16939 |
| Amortization of other acquired intangible assets | 3519 | 3065 |
| Depreciation expense | 3751 | 3596 |
| Other segment items, net (1) | 17097 | 20512 |
| Interest expense | 2499 | 2591 |
| Interest income | (1463) | (1978) |
| Other expense (income), net | (496) | 498 |
| Income tax expense | 2605 | 7955 |
| &nbsp;&nbsp;**Net income** | $**1927** | $**15379** |

---

(1) Other segment items, net includes business applications and technology infrastructure expenses, contractor expenses, professional fees, sales, advertising, and marketing expenses, travel and entertainment, facility expenses, charges or benefits related to changes in the fair values of contingent consideration obligations associated with business combinations, write-offs of long-lived assets, and general overhead expenses, net of software development costs that are capitalized.

***Geographic Information***

Revenue by major geographic region is based upon the geographic location of the customers who purchase our products and services. The geographic locations of distributors, resellers, and systems integrators who purchase and resell our products may be different from the geographic locations of end customers.

Revenue in the Americas includes the United States, Canada, Mexico, Brazil, and other countries in the Americas. Revenue in Europe, the Middle East and Africa ("EMEA") includes the United Kingdom, Germany, Israel, and other countries in EMEA. Revenue in the Asia-Pacific ("APAC") region includes Australia, India, and other Asia-Pacific countries.

The information below summarizes revenue from unaffiliated customers by geographic area for the three months ended April 30, 2025 and 2024:

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** |
|<br>(in thousands) | **2025** | **2024** |
| Americas: |  |  |
| &nbsp;&nbsp;&nbsp;United States | $138218 | $144890 |
| &nbsp;&nbsp;&nbsp;Other | 5392 | 16369 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Americas | 143610 | 161259 |
| EMEA: |  |  |
| &nbsp;&nbsp;United Kingdom | 20943 | 21455 |
| &nbsp;&nbsp;Other | 22112 | 17864 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total EMEA | 43055 | 39319 |
| APAC | 21432 | 20699 |
| &nbsp;&nbsp;&nbsp;**Total revenue** | $**208097** | $**221277** |

---

Our long-lived assets primarily consist of net property and equipment, operating lease right-of-use assets, goodwill and other intangible assets, and deferred income taxes. We believe that our tangible long-lived assets, which consist of our net property and equipment, are exposed to greater geographic area risks and uncertainties than intangible assets, operating lease right-of-use assets, and long-term cost deferrals, because these tangible assets are difficult to move and are relatively illiquid.

Property and equipment, net by geographic area consisted of the following as of April 30, 2025 and January 31, 2025:

---

| | | |
|:---|:---|:---|
|<br>(in thousands) | **April 30,**<br>**2025** | **January 31,**<br>**2025** |
| United States | $29783 | $33740 |
| United Kingdom | 8732 | 6415 |
| Israel | 5977 | 5230 |
| Other countries | 3872 | 3323 |
| &nbsp;&nbsp;&nbsp;**Total property and equipment, net** | $**48364** | $**48708** |

---

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

The following management's discussion and analysis is provided to assist readers in understanding our financial condition, results of operations, and cash flows. This discussion should be read in conjunction with our audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended January 31, 2025 and our unaudited condensed consolidated financial statements and notes thereto contained in this report. This discussion contains a number of forward-looking statements, all of which are based on our current expectations and all of which could be affected by uncertainties and risks. Our actual results may differ materially from the results contemplated in these forward-looking statements as a result of many factors including, but not limited to, those described under "Cautionary Note on Forward-Looking Statements".

**Overview**

***Our Business***

Verint is a leader in customer experience ("CX") automation with a customer base that includes more than 80 of the Fortune 100 companies. The world's most iconic brands use the Verint Open Platform and our team of AI-powered bots to deliver tangible AI business outcomes across the enterprise. Verint is uniquely positioned to help brands increase CX automation with our differentiated AI-powered Open Platform.

Verint is headquartered in Melville, New York, and has approximately 15 offices worldwide, in addition to a number of on-demand, flexible coworking spaces. We have approximately 3,700 employees plus a few hundred contractors around the globe.

***Impact of Macroeconomic Developments***

Our results of operations may be significantly influenced by general macroeconomic and geopolitical conditions, such as recession risks, shifts in government spending, changes in global tariff policies and structures and other trade policies, continued concerns over inflation, elevated interest rates, foreign currency fluctuations, existing and new domestic and foreign laws and regulations, the war in Ukraine, or the war/hostilities between Israel and Hamas or between Israel and Iran or its proxies, all of which are beyond our control.

We believe that these global macroeconomic conditions have impacted customer and partner spending decisions, and have resulted in increased costs. Future impacts on our business and financial results as a result of these conditions are not estimable at this time and depend, in part, on the extent to which these conditions improve or worsen. We will continue to monitor and assess the direct and indirect effects of these macroeconomic and geopolitical developments on our operations, financial condition, and outlook.

See the "Risk Factors" section included in our Annual Report on Form 10-K for the year ended January 31, 2025 for further discussion of the possible impact of these general macroeconomic factors and risks on our business. For additional information on the impact of foreign currency exchange rates, see the "Foreign Currency Exchange Rates' Impact on Results of Operations" section below.

***Key Performance Metric and Trends***

The Verint Open Platform is sold on a subscription basis and for the three months ended April 30, 2025, approximately 85% of our revenue came from our subscription business which we measure using Subscription Annual Recurring Revenue ("ARR").

The following table summarizes our ARR as of the end of each period presented:

---

| | | | |
|:---|:---|:---|:---|
| | **April 30,** | **April 30,** | **% Change** |
|<br>(in thousands) | **2025** | **2024** | **2025 - 2024** |
| **Subscription ARR** | $709992 | $668140 | 6% |

---

Subscription ARR represents the annualized quarterly run-rate value of our active or signed subscription agreements at the end of the period and is comprised of the ARR calculated for our bundled and unbundled SaaS, support, and optional managed services contracts. A portion of ARR is attributable to subscriptions to our AI and AI-powered solutions, which subscriptions may be recognized as either bundled SaaS revenue or as unbundled SaaS revenue depending on the applicable contract terms.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

Under Accounting Standards Codification ("ASC") 606, *Revenue from Contracts with Customers*, we are required to recognize a significant portion of our unbundled SaaS contracts at a point in time when the software is first made available to the customer, or at the beginning of the subscription term, despite the fact that our contracts typically call for billing these amounts annually or more frequently over the life of the subscription. This point-in-time recognition of a portion of our recurring revenue creates significant variability in the revenue recognized period to period based on the timing of the subscription start date and the subscription term and can create a significant difference between the timing of our revenue recognition and the actual customer billing under the contract. For unbundled SaaS contracts, the amount included is generally consistent with the amount that we invoice the customer annually for the term-based license transaction. In the case of acquired contracts that allow for early termination, ARR reflects the annualized amount of committed contracts in the first quarter and then proportionally increases to the remaining amount of annualized ARR in the subsequent three quarters during the first year post acquisition. In cases where SaaS is offered to partners through usage-based contracts, we include the incremental value of usage contracts over a rolling four quarters.

We use ARR to measure the underlying performance of our subscription-based contracts as it normalizes the impact of seasonality, contract duration, and subscription mix (bundled versus unbundled), offering a more consistent view of our underlying business regardless of when revenue is recognized. ARR also provides a more consistent view of cash generation, as it better aligns with our billing cycles and future cash flow generation. ARR should be viewed independently of revenue, and does not represent our revenue under ASC 606 on an annualized basis, as it is an operating metric that is impacted by contract start and end dates and renewal rates. ARR is not intended to be a replacement for forecasts of revenue and does not include revenue reported as nonrecurring revenue in our condensed consolidated statement of operations. ARR does not have any standardized meaning and is therefore unlikely to be comparable to similarly titled measures presented by other companies. Investors should consider our ARR operating measure only in conjunction with our GAAP financial results.

We believe there are three key market trends that are benefiting Verint today: enterprise adoption of AI and CX automation, a changing workforce, and elevated customer expectations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***•* A Changing Workforce:** Brands are facing unprecedented challenges in managing their changing workforce. Increasingly, brands are managing a hybrid workforce of agents and bots, with employees that may be working from anywhere. Providing flexibility for where employees work creates greater challenges in managing and coaching employee teams. And because of the limited resources that are available, brands must drive greater workforce efficiency. They need to find ways of using technology, like AI-powered bots, to augment their workforce. Brands also recognize the need to leverage data and automation to achieve greater efficiency. In addition, the importance of the employee experience continues to grow, and brands must evolve how they recruit, onboard, and retain employees. We believe that these trends benefit Verint as they create demand for new AI-powered solutions like ours that can keep pace with the future of work, including people and bots working together, increased automation, greater employee flexibility, and a greater focus on the voice of the employee.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***•* Elevated Customer Expectations:** Customer expectations for faster, more consistent, and more contextual service and support continue to rise and meeting those expectations is becoming increasingly difficult with legacy technology. The proliferation of customer communication channels and the desire of customers to seamlessly shift between channels creates more complex customer journeys for brands to manage and support. Customers also expect brands to have a deep understanding of the customer's relationship with that brand — an understanding that is unified across the enterprise, regardless of whether the customer touchpoint is in the contact center, on a website, through a mobile app, in the back-office, or in a branch. To develop that deep understanding of the customer relationship, leading brands recognize the need to use specialized, AI-powered solutions like ours to both fuse the data that has traditionally existed in silos across the enterprise and to analyze the data to inform and automate the customer experience.

***Critical Accounting Policies and Estimates***

Note 1, "Summary of Significant Accounting Policies" to the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended January 31, 2025 describes the significant accounting policies and methods used in the preparation of the condensed consolidated financial statements appearing in this report. The accounting policies that reflect our

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

more significant estimates, judgments and assumptions in the preparation of our condensed consolidated financial statements are described in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Item 7 of our Annual Report on Form 10-K for the year ended January 31, 2025, and include the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Revenue recognition;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Accounting for business combinations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Goodwill and other acquired intangible assets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Income taxes; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Accounting for stock-based compensation.

There were no significant changes to our critical accounting policies and estimates during the three months ended April 30, 2025.

**Results of Operations**

***Seasonality and Cyclicality***

Our business exhibits seasonal and cyclical patterns common in the software and technology industry. We typically experience our highest revenue and operating income in the fourth quarter and lowest in the first quarter of each fiscal year, excluding the impact of unusual or nonrecurring items. Order volume tends to peak in the final month of each quarter, with particular concentration in the latter weeks. We attribute these patterns primarily to customer budget cycles and spending patterns, as well as the structure of our sales team's incentive compensation plans. While these seasonal and cyclical trends are consistent with broader industry patterns, these patterns should not be considered reliable predictors of our future performance.

***Subscription Mix***

Our revenue recognition practices vary based on our delivery models. For bundled SaaS subscriptions, we recognize revenue ratably over the contract term, creating a more predictable revenue stream from these arrangements. Much of our reported bundled SaaS revenue in any period stems from customer agreements initiated in prior periods. In contrast, a substantial portion of our unbundled SaaS revenue is recognized upfront upon delivery of the license keys, or when the license term commences, if later, which can create significant period-to-period variability in our reported revenue. This timing difference means increases or decreases in new bundled SaaS sales may not immediately impact reported revenue, while unbundled SaaS contracts create more immediate revenue effects. The timing of multi-year unbundled SaaS renewals can create additional revenue variability. When customers renew unbundled SaaS subscriptions for multiple years, we recognize significantly more revenue upfront compared to one-year renewals. Consequently, periods with higher concentrations of multi-year unbundled SaaS renewals will show elevated revenue recognition, while subsequent periods may reflect comparative decreases even with consistent underlying business performance. Despite these timing differences in revenue recognition, our cash flow patterns remain relatively consistent. Customer billings for both bundled and unbundled SaaS offerings typically follow similar annual billing cycles. To provide investors with greater visibility into our business performance beyond these timing differences, we focus on ARR as a key performance metric as described above.

***Overview of Operating Results***

The following table sets forth a summary of certain key financial information for the three months ended April 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** |
|<br>(in thousands, except per share data) | **2025** | **2024** |
| Revenue | $208097 | $221277 |
| Operating income | $5072 | $24445 |
| Net (loss) income attributable to Verint Systems Inc. common shares | $(2378) | $10041 |
| Net (loss) income per common share attributable to Verint Systems Inc.: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $(0.04) | $0.16 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $(0.04) | $0.16 |

---

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

*Three Months Ended April 30, 2025 compared to Three Months Ended April 30, 2024.* Our revenue decreased approximately $13.2 million, from $221.3 million in the three months ended April 30, 2024 to $208.1 million in the three months ended April 30, 2025. The decrease consisted of a $7.9 million decrease in nonrecurring perpetual revenue and a $5.4 million decrease in nonrecurring professional services and other revenue, partially offset by a $0.1 million increase in recurring revenue. For additional details on our revenue by category, see "—Revenue". Revenue in the Americas, in Europe, the Middle East and Africa ("EMEA"), and in the Asia-Pacific ("APAC") regions represented approximately 69%, 21%, and 10% of our total revenue, respectively, in the three months ended April 30, 2025, compared to approximately 73%, 18%, and 9%, respectively, in the three months ended April 30, 2024. Further details of changes in revenue are provided below.

We reported operating income of $5.1 million in the three months ended April 30, 2025 compared to operating income of $24.4 million in the three months ended April 30, 2024. The decrease in operating income was primarily due to an $18.6 million decrease in gross profit, from $157.5 million to $138.9 million and a $0.7 million increase in operating expenses, from $133.1 million to $133.8 million. The increase in operating expenses consisted of a $3.9 million increase in net research and development expenses and a $0.4 million increase in amortization of other acquired intangible assets, partially offset by a $3.6 million decrease in selling, general and administrative expense. Further details of changes in operating income are provided below.

Net loss attributable to Verint Systems Inc. common shares was $2.4 million and diluted net loss per common share was $0.04 in the three months ended April 30, 2025 compared to net income attributable to Verint Systems Inc. common shares of $10.0 million and diluted net income per common share of $0.16 in the three months ended April 30, 2024. The decrease in net income attributable to Verint Systems Inc. common shares in the three months ended April 30, 2025 was primarily due to a $19.4 million decrease in operating income as described above and a $0.2 million increase in net income attributable to our noncontrolling interest, partially offset by an $5.4 million decrease in our provision for income taxes, a $1.2 million decrease in dividends on preferred stock, and a $0.6 million decrease in total other expense, net. Further details of these changes are provided below.

We employed approximately 3,700 employees plus a few hundred contractors as of April 30, 2025 and 2024.

**Foreign Currency Exchange Rates' Impact on Results of Operations**

A portion of our business is conducted in currencies other than the U.S. dollar, and therefore our revenue, cost of revenue, and operating expenses are affected by fluctuations in applicable foreign currency exchange rates.

When comparing average exchange rates for the three months ended April 30, 2025 to average exchange rates for the three months ended April 30, 2024, the U.S. dollar strengthened relative to the Australian dollar, the Indian rupee, and the Brazilian real, and weakened relative to the British pound sterling, resulting in an overall increase in our revenue and decrease in our expenses on a U.S. dollar-denominated basis. For the three months ended April 30, 2025, had foreign currency exchange rates remained unchanged from rates in effect for the three months ended April 30, 2024, our revenue would have been approximately $0.1 million lower and our cost of revenue and operating expenses on a combined basis would have been approximately $0.1 million higher, which would have resulted in a $0.2 million decrease in our operating income.

**Revenue**

We derive and report our revenue in three categories: (a) recurring revenue, which includes bundled SaaS, unbundled SaaS, hosting services, optional managed services, initial and renewal support revenue, and product warranties, (b) nonrecurring perpetual revenue, which primarily consists of perpetual licenses and hardware, and (c) nonrecurring professional services and other revenue, which consists primarily of installation services, business advisory consulting and training services, and patent royalties.

The following table sets forth revenue by category for the three months ended April 30, 2025 and 2024:

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** | **% Change** |
|<br>(in thousands) | **2025** | **2024** | **2025-2024** |
| **Recurring revenue** |  |  |  |
| Bundled SaaS revenue | $81257 | $65695 | 24% |
| Unbundled SaaS revenue | 66227 | 75288 | (12)% |
| &nbsp;&nbsp;**Total SaaS revenue** | **147484** | **140983** | 5% |
| Optional managed services revenue | 5014 | 5168 | (3)% |
| Support revenue | 21125 | 27377 | (23)% |
| &nbsp;&nbsp;**Total recurring revenue** | **173623** | **173528** | —% |
| **Nonrecurring perpetual revenue** | **17021** | **24900** | (32)% |
| **Nonrecurring professional services and other revenue** | **17453** | **22849** | (24)% |
| &nbsp;&nbsp;**Total revenue** | $**208097** | $**221277** | (6)% |

---

***Recurring Revenue***

*Three Months Ended April 30, 2025 compared to Three Months Ended April 30, 2024.* Recurring revenue increased approximately $0.1 million, from $173.5 million in the three months ended April 30, 2024 to $173.6 million in the three months ended April 30, 2025. The increase consisted of a $6.5 million increase in SaaS revenue, partially offset by a $6.3 million decrease in support revenue and a $0.1 million decrease in optional managed services revenue. The increase in SaaS revenue was due to an increase in bundled SaaS revenue, partially offset by a decrease in unbundled SaaS revenue. The increase in bundled SaaS revenue was primarily due to new customer contracts and existing customers expanding their use of our cloud platform and demand for our AI-powered solutions. The decrease in unbundled SaaS revenue was primarily due to a decrease in conversion transactions and a lower volume of renewals scheduled for the current period. The decrease in support revenue was primarily due to customers migrating to our bundled and unbundled SaaS solutions and customer attrition. Approximately 50% of the support revenue decline was directly attributable to these SaaS transitions. We anticipate a more moderate pace of support conversions going forward as we have largely completed transitioning our customer base from a perpetual license model to recurring SaaS subscriptions.

We expect our revenue mix to continue to shift to our SaaS offerings, which is consistent with our cloud-first strategy and a general market shift from on-premises solutions. Customer subscriptions to the Verint Open Platform may be recognized as either bundled SaaS revenue or as unbundled SaaS revenue depending on the applicable contract terms.

***Nonrecurring Perpetual Revenue***

*Three Months Ended April 30, 2025 compared to Three Months Ended April 30, 2024*. Nonrecurring perpetual revenue decreased approximately $7.9 million, or 32%, from $24.9 million in the three months ended April 30, 2024 to $17.0 million in the three months ended April 30, 2025. The decrease in perpetual revenue was primarily due to reduced demand for our offerings that include hardware with embedded software, we believe driven by short-term macroeconomic uncertainty and a continued shift in spending by our customers towards our SaaS solutions.

***Nonrecurring Professional Services and Other Revenue***

*Three Months Ended April 30, 2025 compared to Three Months Ended April 30, 2024*. Nonrecurring professional services and other revenue decreased approximately $5.3 million, or 24%, from $22.8 million in the three months ended April 30, 2024 to $17.5 million in the three months ended April 30, 2025. The decrease in professional services and other revenue was primarily attributable to a decline in implementation services as a result of the overall shift in our business to a recurring SaaS subscription model, and a decrease in patent royalty revenue primarily due to no further royalties being earned under a royalty agreement.

**Cost of Revenue**

The following table sets forth the cost of revenue by recurring, nonrecurring perpetual, and nonrecurring professional services and other, as well as amortization of acquired technology for the three months ended April 30, 2025 and 2024:

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** | **% Change** |
|<br>(in thousands) | **2025** | **2024** | **2025-2024** |
| Cost of recurring revenue | $42108 | $35923 | 17% |
| Cost of nonrecurring perpetual revenue | 7248 | 8774 | (17)% |
| Cost of nonrecurring professional services and other revenue | 17531 | 17706 | (1)% |
| Amortization of acquired technology | 2308 | 1358 | 70% |
| &nbsp;&nbsp;**Total cost of revenue** | $**69195** | $**63761** | **9%** |

---

***Cost of Recurring Revenue***

Cost of recurring revenue primarily consists of employee compensation and related expenses for our cloud operations and support teams, contractor costs, cloud infrastructure and data center costs, travel expenses relating to optional managed services and support, and royalties due to third parties for software components that are embedded in our cloud-based solutions. Cost of recurring revenue also includes amortization of capitalized software development costs, stock-based compensation expenses, facility costs, and other allocated overhead expenses.

*Three Months Ended April 30, 2025 compared to Three Months Ended April 30, 2024.* Cost of recurring revenue increased approximately $6.2 million, or 17%, from $35.9 million in the three months ended April 30, 2024 to $42.1 million in the three months ended April 30, 2025. The increase was primarily due to an increase in the cost of third-party cloud infrastructure and data center costs in order to support our growing SaaS customer base, and an increase in employee compensation and related expenses primarily due to one-time employee severance and related charges. Our recurring revenue gross margins decreased from 79% in the three months ended April 30, 2024 to 76% in the three months ended April 30, 2025, primarily driven by a shift in our SaaS revenue mix from unbundled to bundled, and an increase in recurring costs as described above.

***Cost of Nonrecurring Perpetual Revenue***

Cost of nonrecurring perpetual revenue primarily consists of hardware material costs, employee compensation and related expenses, freight and shipping costs, and royalties due to third parties for software components that are embedded in our on-premises software solutions. Cost of nonrecurring perpetual revenue also includes amortization of capitalized software development costs, employee compensation and related expenses associated with our global operations, facility costs, and other allocated overhead expenses.

*Three Months Ended April 30, 2025 compared to Three Months Ended April 30, 2024.* Cost of nonrecurring perpetual revenue decreased approximately $1.6 million, or 17%, from $8.8 million in the three months ended April 30, 2024 to $7.2 million in the three months ended April 30, 2025. The decrease was primarily attributable to a corresponding decrease in nonrecurring perpetual revenue as described above. Our nonrecurring perpetual gross margins decreased from 65% in the three months ended April 30, 2024 to 57% in the three months ended April 30, 2025, primarily driven by a reduction in nonrecurring perpetual revenue.

***Cost of Nonrecurring Professional Services and Other Revenue***

Cost of nonrecurring professional services and other revenue primarily consists of employee compensation and related expenses, contractor costs, and travel expenses relating to installation, training and consulting services. Cost of nonrecurring professional services and other revenue also includes employee compensation and related expenses associated with our global operations, facility costs, and other allocated overhead expenses.

*Three Months Ended April 30, 2025 compared to Three Months Ended April 30, 2024.* Cost of nonrecurring professional services and other revenue decreased approximately $0.2 million, or 1%, from $17.7 million in the three months ended April 30, 2024 to $17.5 million in the three months ended April 30, 2025. Our nonrecurring professional services and other gross margins decreased from 23% in the three months ended April 30, 2024 to 0% in the three months ended April 30, 2025, primarily due to nonrecurring professional services and other revenue decreasing at a faster rate than nonrecurring professional services and other costs driven by reduced implementation services and a decrease in patent royalty revenue as described above.

***Amortization of Acquired Technology***

Amortization of acquired technology consists of the amortization of technology assets acquired in connection with business combinations.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

*Three Months Ended April 30, 2025 compared to Three Months Ended April 30, 2024.* Amortization of acquired technology increased approximately $0.9 million, or 70%, from $1.4 million in the three months ended April 30, 2024 to $2.3 million in the three months ended April 30, 2025. The increase was attributable to amortization expense associated with acquired technology intangible assets from recent business combinations, partially offset by acquired technology intangible assets from historical business combinations becoming fully amortized.

Further discussion regarding our business combinations appears in Note 5, "Business Combinations and Asset Acquisitions" to our condensed consolidated financial statements included under Part I, Item 1 of this report.

**Research and Development, Net**

Research and development expenses, net ("R&D") consist primarily of personnel and subcontracting expenses, facility costs, and other allocated overhead, net of certain software development costs that are capitalized and benefits derived from participation in government-sponsored programs in certain jurisdictions for the support of research and development activities conducted in those locations. Software development costs are capitalized upon the establishment of technological feasibility and continue to be capitalized through the general release of the related software product.

The following table sets forth R&D for the three months ended April 30, 2025 and 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** | **% Change** |
|<br>(in thousands) | **2025** | **2024** | **2025-2024** |
| Research and development, net | $40641 | $36730 | 11% |

---

*Three Months Ended April 30, 2025 compared to Three Months Ended April 30, 2024.* R&D increased approximately $3.9 million, or 11%, from $36.7 million in the three months ended April 30, 2024 to $40.6 million in the three months ended April 30, 2025. This increase was primarily attributable to a $4.3 million increase in employee compensation and related expenses primarily due to increased investment in R&D headcount and one-time employee severance and related charges, and a $1.6 million increase in cloud-based R&D infrastructure costs primarily attributable to a shift from on-premises to cloud R&D labs for development teams supporting R&D and product development, partially offset by a $1.7 million benefit from the reversal of consideration payable under an acquisition related key employee incentive plan as the achievement of the underlying performance criteria is no longer probable.

**Selling, General and Administrative Expenses**

Selling, general and administrative expenses ("SG&A") consist primarily of personnel costs and related expenses, professional fees, changes in the fair values of our obligations under contingent consideration arrangements, sales and marketing expenses, including travel costs, sales commissions and sales referral fees, facility costs, communication expenses, and other administrative expenses.

The following table sets forth SG&A for the three months ended April 30, 2025 and 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** | **% Change** |
|<br>(in thousands) | **2025** | **2024** | **2025-2024** |
| Selling, general and administrative | $89670 | $93276 | (4)% |

---

*Three Months Ended April 30, 2025 compared to Three Months Ended April 30, 2024.* SG&A decreased approximately $3.6 million, or 4%, from $93.3 million in the three months ended April 30, 2024 to $89.7 million in the three months ended April 30, 2025. This decrease was primarily due to a $7.0 million benefit due to a change in the fair value of our obligations under contingent consideration arrangements as a result of revised outlooks related to a recent acquisition, and a $1.8 million benefit from the reversal of consideration payable under an acquisition related key employee incentive plan as the achievement of the underlying performance criteria is no longer probable, partially offset by an increase of $4.6 million in employee compensation and related expenses primarily due to an increase in headcount supporting SG&A activities and one-time employee severance and related charges.

**Amortization of Other Acquired Intangible Assets**

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

Amortization of other acquired intangible assets consists of the amortization of certain intangible assets acquired in connection with business combinations.

The following table sets forth the amortization of other acquired intangible assets for the three months ended April 30, 2025 and 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** | **% Change** |
|<br>(in thousands) | **2025** | **2024** | **2025-2024** |
| Amortization of other acquired intangible assets | $3519 | $3065 | 15% |

---

*Three Months Ended April 30, 2025 compared to Three Months Ended April 30, 2024.* Amortization of other acquired intangible assets increased approximately $0.4 million, or 15%, from $3.1 million in the three months ended April 30, 2024 to $3.5 million in the three months ended April 30, 2025. The increase was attributable to amortization expense associated with acquired intangible assets from recent business combinations, partially offset by acquired customer-related intangible assets from historical business combinations becoming fully amortized.

Further discussion regarding our business combinations appears in Note 5, "Business Combinations and Asset Acquisitions" to our condensed consolidated financial statements included under Part I, Item 1 of this report.

**Other Expense, Net**

The following table sets forth total other expense, net for the three months ended April 30, 2025 and 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** | **% Change** |
|<br>(in thousands) | **2025** | **2024** | **2025-2024** |
| Interest income | $1463 | $1978 | (26)% |
| Interest expense | (2499) | (2591) | (4)% |
| Other income (expense): |  |  |  |
| &nbsp;&nbsp;Foreign currency gains (losses), net | 723 | (537) | \* |
| &nbsp;&nbsp;&nbsp;Other, net | (227) | 39 | \* |
| Total other income (expense), net | 496 | (498) | (200)% |
| &nbsp;&nbsp;**Total other expense, net** | $**(540)** | $**(1111)** | (51)% |

---

\* Percentage is not meaningful.

*Three Months Ended April 30, 2025 compared to Three Months Ended April 30, 2024.* Total other expense, net, decreased by $0.6 million from $1.1 million in the three months ended April 30, 2024 to $0.5 million in the three months ended April 30, 2025.

Interest income decreased from $2.0 million in the three months ended April 30, 2024 to $1.5 million in the three months ended April 30, 2025 due to lower average balances in money market fund investments, which are included in cash and cash equivalents.

Interest expense decreased to $2.5 million in the three months ended April 30, 2025 from $2.6 million in the three months ended April 30, 2024 primarily due to lower interest rates on borrowings under the revolving credit facility. Further discussion regarding our borrowings appears under "Financing Arrangements" below and in Note 7, "Debt" to our condensed consolidated financial statements included under Part I, Item 1 of this report.

We recorded $0.7 million of net foreign currency gains in the three months ended April 30, 2025, and $0.5 million of net foreign currency losses during the three months ended April 30, 2024. Our foreign currency gains in the current period were primarily from fluctuations associated with the exchange rate movement of the U.S. dollar against the Mexican peso, the Brazilian real, and the Australian dollar.

**Provision for Income Taxes**

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

The following table sets forth our provision for income taxes for the three months ended April 30, 2025 and 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** | **% Change** |
|<br>(in thousands) | **2025** | **2024** | **2025-2024** |
| Provision for income taxes | $2605 | $7955 | (67)% |

---

*Three Months Ended April 30, 2025 compared to Three Months Ended April 30, 2024.* Our effective income tax rate was 57.5% for the three months ended April 30, 2025, compared to an effective income tax rate of 34.1% for the three months ended April 30, 2024.

For the three months ended April 30, 2025, the effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to the U.S. taxation of certain foreign activities and the income tax impacts of stock-based compensation, offset by the benefit of certain domestic tax credits and lower statutory rates in certain foreign jurisdictions. The result was an income tax provision of $2.6 million on pretax income of $4.5 million, which represented an effective income tax rate of 57.5%.

For the three months ended April 30, 2024, the effective tax rate differs from the U.S. federal statutory rate of 21% primarily due to the U.S. taxation of certain foreign activities, offset by lower statutory rates in certain foreign jurisdictions. The result was an income tax provision of $8.0 million on pretax income of $23.3 million, which represented an effective income tax rate of 34.1%.

The Organization for Economic Co-operation and Development ("OECD") Pillar 2 guidelines address the increasing digitalization of the global economy, re-allocating taxing rights among countries. The European Union and many other member states have committed to adopting Pillar 2 which calls for a global minimum tax of 15% to be effective for tax years beginning in 2024. Certain jurisdictions in which we operate have enacted Pillar 2 legislation and others are considering changes to their tax laws to adopt the Pillar 2 global minimum tax. We are monitoring developments and evaluating the impacts of new rules as they are published, including eligibility to qualify for safe harbor rules. Pillar 2 did not have a material impact on our income tax expense for the three months ended April 30, 2025 and 2024.

**Liquidity and Capital Resources**

***Overview***

Our primary recurring source of cash is the collection of proceeds from the sale of products and services to our customers, including cash periodically collected in advance of delivery or performance.

On May 7, 2020, an affiliate (the "Apax Investor") of Apax Partners ("Apax") purchased $200.0 million of our Series A convertible preferred stock ("Series A Preferred Stock") with an initial conversion price of $53.50 per share. Following the spin-off (the "Spin-Off) of Cognyte Software Ltd., whose business and operations consist of our former Cyber Intelligence Solutions business, the Series A Preferred Stock conversion price was adjusted to $36.38 per share. In connection with the completion of the Spin-Off, on April 6, 2021, the Apax Investor purchased $200.0 million of our Series B convertible preferred stock ("Series B Preferred Stock"), which is convertible at a conversion price of $50.25 per share. As of April 30, 2025, Apax's ownership in us on an as-converted basis was approximately 13.7%.

Each series of Preferred Stock paid dividends at an annual rate of 5.2% until May 7, 2024, and thereafter pays at a rate of 4.0%, subject to adjustment under certain circumstances. Dividends will be cumulative and payable semiannually in arrears in cash. All dividends that are not paid in cash will remain accumulated dividends with respect to each share of Preferred Stock. We used the proceeds from the Apax investment to repay outstanding indebtedness, to fund a portion of our stock repurchase programs (as described below under "Liquidity and Capital Resources Requirements"), and/or for general corporate purposes. Please refer to Note 9, "Convertible Preferred Stock", to our condensed consolidated financial statements included under Part I, Item 1 of this report for more information regarding the Apax convertible preferred stock investment.

Our primary recurring use of cash is payment of our operating costs, which consist primarily of employee-related expenses, such as compensation and benefits, as well as general operating expenses for cloud operations, marketing, facilities and overhead costs, and capital expenditures. We also utilize cash for debt service, securities repurchases, dividends on the

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

Preferred Stock, and business acquisitions. Cash generated from operations, along with our existing cash, cash equivalents, and short-term investments, are our primary sources of operating liquidity.

We have historically expanded our business in part by investing in strategic growth initiatives, including acquisitions of products, technologies, and businesses. We may finance such acquisitions using cash, debt, stock, or a combination of the foregoing, however, we have used cash as consideration for substantially all of our historical business combinations and asset acquisitions, including approximately $9.2 million of net cash expended for business combinations and asset acquisitions during the three months ended April 30, 2024. There were no business combinations or asset acquisitions during the three months ended April 30, 2025. Please refer to Note 5, "Business Combinations and Asset Acquisitions", to our condensed consolidated financial statements included under Part I, Item 1 of this report for more information regarding our recent business combinations and asset acquisitions.

We continually examine our options with respect to terms and sources of existing and future short-term and long-term capital resources to enhance our operating results and to ensure that we retain financial flexibility, and may from time to time elect to raise capital through the issuance of additional equity or the incurrence of additional debt. We will need to either refinance or repay all of the debt under our 2021 Notes within the next year. This refinancing may include utilizing our Revolving Credit Facility, along with other available sources of cash, to repay some or all of the 2021 Notes.

A portion of our operating income is earned outside the United States. Cash, cash equivalents, short-term investments, and restricted cash, restricted cash equivalents, and restricted bank time deposits (excluding any long-term portions) held by our subsidiaries outside of the United States were $149.9 million and $156.2 million as of April 30, 2025 and January 31, 2025, respectively, and are generally used to fund the subsidiaries' operating requirements and to invest in growth initiatives, including business acquisitions.

We currently intend to continue to indefinitely reinvest a portion of the earnings of our foreign subsidiaries, which, as a result of the 2017 Tax Cuts and Jobs Act, may now be repatriated without incurring additional U.S. federal income taxes.

Should other circumstances arise whereby we require more capital in the United States than is generated by our domestic operations, or should we otherwise consider it in our best interests, we could repatriate future earnings from foreign jurisdictions, which could result in higher effective tax rates. As noted above, we currently intend to indefinitely reinvest a portion of the earnings of our foreign subsidiaries to finance foreign activities. Except to the extent that earnings of our foreign subsidiaries have been subject to U.S. taxation as of April 30, 2025, and withholding taxes of $4.2 million accrued as of January 31, 2025 with respect to certain identified cash that may be repatriated to the United States, we have not provided tax on the outside basis difference of foreign subsidiaries nor have we provided for any additional withholding or other tax that may be applicable should a future distribution be made from any unremitted earnings of foreign subsidiaries. Due to complexities in the laws of the foreign jurisdictions and the assumptions that would have to be made, it is not practicable to estimate the total amount of income and withholding taxes that would have to be provided on such earnings.

The following table summarizes our total cash, cash equivalents, restricted cash, cash equivalents, and bank time deposits, and short-term investments, as well as our total debt, as of April 30, 2025 and January 31, 2025:

---

| | | |
|:---|:---|:---|
|<br>(in thousands) | **April 30,**<br>**2025** | **January 31,**<br>**2025** |
| Cash and cash equivalents | $180870 | $215707 |
| Short-term investments | 449 | 1344 |
| **Total cash, cash equivalents, and short-term investments** | $**181319** | $**217051** |
| **Total debt, including current portions** | $**413117** | $**412753** |

---

***Capital Allocation Framework***

As noted above, after cash utilization required for working capital, capital expenditures, required debt service, and dividends on the Preferred Stock, we expect that our primary usage of cash will be for business combinations, repayment or repurchases of outstanding indebtedness, and/or securities repurchases under repurchase programs that may be in place from time to time (subject to the terms of our Credit Agreement). Please see the "Liquidity and Capital Resources Requirements" section below for further information about our recent stock repurchase program.

***Condensed Consolidated Cash Flow Activity***

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

The following table summarizes selected items from our condensed consolidated statements of cash flows for the three months ended April 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>April 30,** | **Three Months Ended<br>April 30,** |
|<br>(in thousands) | **2025** | **2024** |
| Net cash provided by operating activities | $26323 | $60717 |
| Net cash used in investing activities | (5421) | (14135) |
| Net cash used in financing activities | (58883) | (50737) |
| Effect of foreign currency exchange rate changes on cash and cash equivalents | 3144 | (848) |
| **Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents** | $**(34837)** | $**(5003)** |

---

Our financing activities used $58.9 million of net cash and our investing activities used $5.4 million of net cash during the three months ended April 30, 2025, which was partially offset by $26.3 million of cash generated from operating activities. Further discussion of these items appears below.

**Net Cash Provided by Operating Activities**

Net cash provided by operating activities is driven primarily by our net income or loss, as adjusted for non-cash items and working capital changes. Operating activities generated $26.3 million of net cash during the three months ended April 30, 2025, compared to $60.7 million generated during the three months ended April 30, 2024. Our operating cash flow in the current period decreased primarily due to lower net income adjusted for non-cash expenses as a result of lower operating income, the timing of customer collections, and the collection of a long-standing foreign withholding tax receivable in the prior period.

Our cash flow from operating activities can fluctuate from period to period due to several factors, including the timing of our billings and collections, the timing and amounts of interest, income tax and other payments, and our operating results.

**Net Cash Used in Investing Activities**

During the three months ended April 30, 2025, our investing activities used $5.4 million of net cash, consisting primarily of $6.0 million of payments for property, equipment and capitalized software development, and $0.3 million of net cash utilized for business combinations and asset acquisitions, partially offset by $0.9 million of net proceeds from maturities of short-term investments.

During the three months ended April 30, 2024, our investing activities used $14.1 million of net cash, consisting primarily of $9.2 million of net cash utilized for business combinations and asset acquisitions, $6.1 million of payments for property, equipment and capitalized software development, and $0.1 million of net purchases of short-term investments, partially offset by $1.3 million of net proceeds from the divestiture of our manual quality managed services business during the three months ended January 31, 2024.

We had no significant commitments for capital expenditures at April 30, 2025.

**Net Cash Used in Financing Activities**

For the three months ended April 30, 2025, our financing activities used $58.9 million of net cash, consisting primarily of $41.8 million of payments to repurchase common stock, $8.0 million of payments of Preferred Stock dividends, $6.8 million for the financing portion of payments under contingent consideration arrangements related to prior business combinations, $2.2 million paid for debt-related issuance fees, and $0.3 million of finance lease payments and other financing obligations, partially offset by $0.2 million of cash received related to the sale of an insignificant product line in March 2023.

For the three months ended April 30, 2024, our financing activities used $50.7 million of net cash, consisting primarily of $37.1 million of payments to repurchase common stock, $10.4 million of payments of Preferred Stock dividends, $2.7 million for the financing portion of payments under contingent consideration arrangements related to prior business combinations, $0.6 million of finance lease payments and other financing obligations, and a $0.2 million distribution to a noncontrolling shareholder of one of our subsidiaries, partially offset by $0.2 million of cash received related to the sale of an insignificant product line in March 2023.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

***Liquidity and Capital Resources Requirements***

On March 25, 2025, we entered into an amendment to the Credit Agreement (the "Fifth Amendment"), which extends the maturity date of our revolving credit facility to March 25, 2030, subject to certain conditions described below and increases the aggregate borrowing commitments from $300.0 million to $500.0 million (the "Revolving Credit Facility"). Based on past performance and current expectations, we believe that our cash, cash equivalents, and short-term investments, together with cash generated from operations and access to our Revolving Credit Facility, will be sufficient to meet anticipated operating costs, required payments of principal and interest, dividends on Preferred Stock, working capital needs, ordinary course capital expenditures, research and development spending, and other commitments for at least the next 12 months from the issuance of our condensed consolidated financial statements. Currently, we have no plans to pay any cash dividends on our common stock, which are subject to certain restrictions under our Credit Agreement (as defined below).

Our liquidity could be negatively impacted by a decrease in demand for our products and services, including the impact of changes in customer buying behavior due to circumstances over which we have no control, including, but not limited to, the effects of general economic conditions or geopolitical developments. If we decide to make additional business acquisitions or otherwise require additional funds, we may need to raise additional capital, which could involve the issuance of additional equity or debt securities or an increase in our borrowings under our credit facility. We anticipate refinancing the majority, if not all, of the debt under our 2021 Notes within the next year.

**Repurchases of Common Stock**

On December 7, 2022, we announced that our board of directors had authorized a stock repurchase program for the period from December 12, 2022 until January 31, 2025, whereby we may repurchase shares of common stock in an amount not to exceed, in the aggregate, $200.0 million, which was completed during the six months ended July 31, 2024.

On September 4, 2024, we announced that our board of directors had authorized a new stock repurchase program for the period from August 29, 2024 until August 29, 2026, whereby we may repurchase shares of common stock not to exceed, in the aggregate, $200.0 million.

During the year ended January 31, 2025, we repurchased approximately 1,701,000 shares of our common stock for a cost of $52.9 million under the prior stock repurchase program, approximately 689,000 shares of common stock for a cost of $18.7 million under the new stock repurchase program. We also repurchased approximately 25,000 shares for a cost of $0.7 million to facilitate income tax withholding or tax payments. During the three months ended April 30, 2025, we repurchased approximately 2,449,000 shares of common stock for a cost of $40.7 million under the new stock repurchase program, with $0.2 million of these repurchases settled in cash in early May 2025. We also repurchased approximately 83,000 shares to facilitate income tax withholding or payments as described above for a cost of $1.3 million.

Our share repurchases in excess of issuances are subject to a 1% excise tax enacted by the Inflation Reduction Act ("IRA"). We recognized excise tax of $0.3 million as part of the cost basis of shares acquired in the condensed consolidated statements of stockholders' equity during the three months ended April 30, 2025.

Repurchases were funded with available cash in the United States.

***Financing Arrangements***

**2021 Notes**

On April 9, 2021, we issued $315.0 million in aggregate principal amount of our 2021 Notes, which mature on April 15, 2026, unless earlier converted by the holders pursuant to their terms. The 2021 Notes are unsecured and pay interest in cash semiannually in arrears at a rate of 0.25% per annum.

We used a portion of the net proceeds from the issuance of the 2021 Notes to pay the costs of the Capped Calls described below. We also used a portion of the net proceeds from the issuance of the 2021 Notes, together with the net proceeds from the April 6, 2021 issuance of $200.0 million of Series B Preferred Stock, to repay a portion of the outstanding indebtedness under our Credit Agreement described below, to terminate an interest rate swap agreement, and to repurchase shares of our common stock. The remainder is being used for working capital and other general corporate purposes.

The 2021 Notes are convertible into shares of our common stock at an initial conversion rate of 16.1092 shares per $1,000 principal amount of 2021 Notes, which represents an initial conversion price of approximately $62.08 per share, subject to

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

adjustment upon the occurrence of certain events, and subject to customary anti-dilution adjustments. Prior to January 15, 2026, the 2021 Notes are convertible only upon the occurrence of certain events and during certain periods, and will be convertible thereafter at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2021 Notes. Upon conversion of the 2021 Notes, holders will receive cash up to the aggregate principal amount, with any remainder to be settled with cash or common stock, or a combination thereof, at our election. As of April 30, 2025, the 2021 Notes were not convertible.

Based on the closing market price of our common stock on April 30, 2025, the if-converted value of the 2021 Notes was less than their aggregate principal amount.

**Capped Calls**

In connection with the issuance of the 2021 Notes, on April 6, 2021 and April 8, 2021, we entered into capped call transactions (the "Capped Calls") with certain counterparties. The Capped Calls are generally intended to reduce the potential dilution to our common stock upon any conversion of the 2021 Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted 2021 Notes, in the event that at the time of conversion our common stock price exceeds the conversion price, with such reduction and/or offset subject to a cap.

The Capped Calls exercise price is equal to the $62.08 initial conversion price of each of the 2021 Notes, and the cap price is $100.00, each subject to certain adjustments under the terms of the Capped Calls. The Capped Calls have the economic effect of increasing the conversion price of the 2021 Notes from $62.08 per share to $100.00 per share. Our exercise rights under the Capped Calls generally trigger upon conversion of the 2021 Notes, and the Capped Calls terminate upon maturity of the 2021 Notes, or the first day the 2021 Notes are no longer outstanding. As of April 30, 2025, no Capped Calls have been exercised.

Pursuant to their terms, the Capped Calls qualify for classification within stockholders' equity, and their fair value is not remeasured and adjusted, as long as they continue to qualify for stockholders' equity classification. We paid approximately $41.1 million for the Capped Calls, including applicable transaction costs, which was recorded as a reduction to additional paid-in capital.

**Credit Agreement**

On June 29, 2017, we entered into a credit agreement with certain lenders and terminated a prior credit agreement. The credit agreement was amended in 2018, 2020, 2021, 2023, and 2025, as further described below (as amended, the "Credit Agreement").

The Credit Agreement initially was comprised of a $425.0 million term loan that was fully repaid, and a $300.0 million revolving credit facility (the "Prior Revolving Credit Facility"). During the three months ended April 30, 2021, we repaid $309.0 million of our Term Loan, reducing the outstanding principal balance to $100.0 million. On April 27, 2023, we repaid the remaining $100.0 million outstanding principal balance on our Term Loan utilizing proceeds from borrowings under our Prior Revolving Credit Facility.

On March 25, 2025, we entered into the Fifth Amendment, which extends the maturity date of our revolving credit facility to March 25, 2030, subject to certain conditions as discussed below, and increases the aggregate borrowing commitments from $300.0 million to $500.0 million. Effective March 25, 2025, borrowings under the Credit Agreement bear interest, at our option, at either: (i) the ABR, plus the applicable margin therefor or (ii) Term Secured Overnight Financing Rate ("Term SOFR") plus the applicable margin. The applicable margin is determined based on our Leverage Ratio and ranges from 0.50% to 1.25% for ABR borrowings and from 1.50% to 2.25% for Term SOFR borrowings. As provided in the Fifth Amendment, the Revolving Credit Facility matures on March 25, 2030, provided that from and after January 7, 2026, the maturity date of the Revolving Credit Facility will be accelerated if we do not satisfy a minimum level of liquidity equal to (x) the principal amount outstanding under the 2021 Notes plus (y) $100.0 million (taking into account undrawn capacity under the expanded Revolving Credit Facility) at any time that more than $35.0 million in principal amount remains outstanding (and not cash collateralized) under the 2021 Notes.

As of April 30, 2025, the $100.0 million in borrowings under the Revolving Credit Facility, and as of January 31, 2025, the $100.0 million in borrowings under the Prior Revolving Credit Facility, were included in debt, current on our condensed consolidated balance sheet. For borrowings under the Revolving Credit Facility, the applicable margin is determined by reference to our Consolidated Total Debt to Consolidated EBITDA (each as defined in the Credit Agreement) leverage ratio (the "Leverage Ratio"). As of April 30, 2025, the interest rate on our Revolving Credit Facility borrowings was 5.82%. In

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

addition, we are required to pay a commitment fee with respect to unused availability under the Revolving Credit Facility at rates per annum determined by reference to our Leverage Ratio.

The Credit Agreement contains certain customary affirmative and negative covenants for credit facilities of this type. The Credit Agreement also contains a financial covenant that, solely with respect to the Revolving Credit Facility generally requires us to maintain a Leverage Ratio of no greater than 4.5 to 1. The Credit Agreement further provides that, upon consummation of a Permitted Acquisition (as defined in the Credit Agreement) for consideration in an aggregate amount equal to or greater than $100.0 million, we may increase the Leverage Ratio to 5.0 to 1 during the quarter in which the Permitted Acquisition is consummated or, at our election, the immediately following fiscal quarter, and for each of the three succeeding fiscal quarters, subject to the restrictions described in the Credit Agreement. At April 30, 2025, our Leverage Ratio was approximately 1.0 to 1. The limitations imposed by the covenants are subject to certain exceptions as detailed in the Credit Agreement.

Our obligations under the Credit Agreement are guaranteed by each of our direct and indirect existing and future material domestic wholly owned restricted subsidiaries and are secured by a security interest in substantially all of our assets and the assets of the guarantor subsidiaries, subject to certain exceptions.

The Credit Agreement provides for events of default with corresponding grace periods that we believe are customary for credit facilities of this type. Upon an event of default, all of our obligations owed under the Credit Agreement may be declared immediately due and payable, and the lenders' commitments to make loans under the Credit Agreement may be terminated.

***Contractual Obligations***

Our principal commitments primarily consist of current debt, dividends on Preferred Stock, leases for office space and open non-cancellable purchase orders. As of April 30, 2025, we believe there have been no material changes to our contractual obligations from those disclosed in Part II, Item 7. — Management's Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K for the year ended January 31, 2025. For additional information regarding our leases, debt and our commitments and contingencies, see Note 15, "Leases", in the Form 10-K and Note 7, "Debt", Note 9, "Convertible Preferred Stock", and Note 15, "Commitments and Contingencies" in the notes to our condensed consolidated financial statements included in Part I, Item 1 of this report.

As of April 30, 2025, our total operating lease liabilities were $34.7 million, of which $5.7 million is included within accrued expenses and other current liabilities (current portions), and $29.0 million is included as operating lease liabilities (long-term portions), on our condensed consolidated balance sheets.

It is not our business practice to enter into off-balance sheet arrangements. However, in the normal course of business, we enter into contracts in which we make representations and warranties that guarantee the performance of our products and services and provide indemnifications of varying scopes to customers against claims of intellectual property infringement made by third parties arising from the use of our products. We also have contractual indemnification agreements with our directors, officers, and certain senior executives. Historically, there have been no significant losses related to such guarantees or indemnification provisions.

Our condensed consolidated balance sheet at April 30, 2025 included $68.0 million of non-current tax reserves (including interest and penalties of $9.0 million), net of related benefits for uncertain tax positions. We do not expect to make any significant payments for these uncertain tax positions within the next 12 months.

***Contingent Payments Associated with Business Combinations and Asset Acquisitions***

In connection with certain of our business combinations, we have agreed to make contingent cash payments to the former owners of the acquired companies based upon the achievement of performance targets following the acquisition dates.

For the three months ended April 30, 2025, we made $6.4 million of payments under contingent consideration arrangements. As of April 30, 2025, potential future cash payments under contingent consideration arrangements totaled $48.1 million, the estimated fair value of which was $8.2 million, of which $5.6 million was recorded within accrued expenses and other current liabilities, and $2.6 million was recorded within other liabilities. The performance periods associated with these potential payments extend through October 2027.

In July 2023, we entered into an agreement to acquire source code that qualified as an asset acquisition and provides for additional consideration contingent upon achieving certain performance targets for the years ending January 31, 2025 and 2026 of up to $5.0 million, plus the opportunity to receive additional payments from us based on any revenue we receive from sales

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

of products based on the acquired technology in adjacent markets. During the year ended January 31, 2025, we made a $0.3 million noncontingent prepayment against the first period earn-out, and accrued the remaining $1.7 million of the minimum guaranteed contingent consideration upon achieving certain milestones by certain dates. During the three months ended April 30, 2025, we made a $0.7 million payment against the first period earn-out, with the remaining $1.0 million recorded within accrued expenses and other current liabilities as of April 30, 2025.

Refer to Note 5, "Business Combinations and Asset Acquisitions" to our condensed consolidated financial statements included under Part I, Item 1 of this report for further details.

**Recent Accounting Pronouncements**

For a description of recent accounting pronouncements, and the potential impact of these pronouncements on our condensed consolidated financial statements, see Note 1, "Basis of Presentation and Significant Accounting Policies" to the condensed consolidated financial statements in Part I, Item 1 of this report.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

**Item 3. Quantitative and Qualitative Disclosures About Market Risk**

Market risk represents the risk of loss that may impact our financial condition due to adverse changes in financial market prices and rates. We are exposed to market risk related to changes in interest rates and foreign currency exchange rate fluctuations. To manage the volatility relating to interest rate and foreign currency risks, we periodically enter into derivative instruments including foreign currency forward exchange contracts and interest rate swap agreements. It is our policy to use derivative instruments only to the extent considered necessary to meet our risk management objectives. We use derivative instruments solely to reduce the financial impact of these risks and do not use derivative instruments for speculative purposes.

**Interest Rate Risk on Our Debt**

In April 2021, we issued $315.0 million in aggregate principal amount of the 2021 Notes. Prior to January 15, 2026, the 2021 Notes will be convertible only upon the occurrence of certain events and during certain periods, and will be convertible thereafter at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the 2021 Notes. Upon conversion of the 2021 Notes, holders will receive cash up to the aggregate principal amount, with any remainder to be settled with cash or common stock, or a combination thereof, at our election. Concurrent with the issuance of the 2021 Notes, we entered into capped call transactions with certain counterparties. These separate transactions were completed to reduce our exposure to potential dilution upon conversion of the 2021 Notes.

The 2021 Notes have a fixed annual interest rate of 0.25% and therefore do not have interest rate risk exposure. However, the fair values of the 2021 Notes are subject to interest rate risk, market risk, and other factors due to the convertible feature. The fair values of the 2021 Notes are also affected by our common stock price. Generally, the fair values of the 2021 Notes will increase as interest rates fall and/or our common stock price increases, and decrease as interest rates rise and/or our common stock price decreases. Changes in the fair values of the 2021 Notes do not impact our financial position, cash flows, or results of operations due to the fixed nature of the debt obligations. We do not carry the 2021 Notes at fair value on our condensed consolidated balance sheet, but we report the fair value of the 2021 Notes for disclosure purposes.

Interest rates on loans under the Credit Agreement are based on either: (i) the ABR, plus the applicable rate margin therefor or (ii) Term SOFR, plus the applicable margin therefor. Prior to the Fifth Amendment, the applicable margin ranged from 0.25% to 1.25% for ABR borrowings and from 1.25% to 2.25% for Term SOFR borrowings. Under the Fifth Amendment, the applicable margin ranges from 0.50% to 1.25% for ABR borrowings and from 1.50% to 2.25% for Term SOFR borrowings.

For loans under the Revolving Credit Facility, the margin is determined by reference to our Consolidated Total Debt to Consolidated EBITDA leverage ratio. As of April 30, 2025, the interest rate on our $100.0 million of borrowings under our Revolving Credit Facility was 5.82%. A hypothetical 10% change in interest rates during any of the periods presented would not have had a material impact on our financial statements.

**Inflation Risk**

We believe that current macroeconomic factors, including among other things, high prices due to inflation and changes in the interest rate environment, are impacting customer and partner spending decisions. Given the current macroeconomic environment, we continue to look for ways to manage our costs and mitigate any changes in our customers' purchasing behavior that may occur due to these or other factors. If our costs, in particular labor, sales and marketing, and cloud hosting costs, become subject to sustained or increased inflationary pressure, we may be unable to fully offset such higher costs through price increases, which could harm our business, financial condition, and results of operations.

The section entitled "Quantitative and Qualitative Disclosures About Market Risk" under Part II, Item 7A of our Annual Report on Form 10-K for the year ended January 31, 2025 provides detailed quantitative and qualitative discussions of the market risks affecting our operations. Our exposure to market risk has not changed materially during the three months ended April 30, 2025, other than as described above.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

**Item 4. Controls and Procedures**

**Evaluation of Disclosure Controls and Procedures**

Management conducted an evaluation under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of April 30, 2025. Disclosure controls and procedures are those controls and other procedures that are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported, within the time periods specified by the rules and forms promulgated by the SEC. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. As a result of this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of April 30, 2025.

**Changes in Internal Control Over Financial Reporting**

There were no changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the three months ended April 30, 2025, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**Inherent Limitations on Effectiveness of Controls**

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system will be achieved. Further, the design of a control system must reflect the impact of resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the possibility that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors. Additionally, controls can be circumvented by individual acts, by collusion of two or more people, or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all possible conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

**Part II**

**Item 1. Legal Proceedings**

See Note 15, "Commitments and Contingencies" to our condensed consolidated financial statements under Part I, Item 1 of this report for information regarding our legal proceedings.

**Item 1A. Risk Factors**

There have been no material changes to the Risk Factors described in Part I "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended January 31, 2025. In addition to the other information set forth in this Quarterly Report, you should carefully consider the risks discussed in our Annual Report on Form 10-K, which could materially affect our business, financial condition, or operating results. The risks described in our Annual Report on Form 10-K are not the only risks facing us, however. Additional risks and uncertainties not currently known to us or that we currently deem to be insignificant also may materially and adversely affect our business, financial condition, or operating results in the future.

**Item 2. &nbsp;&nbsp;&nbsp;&nbsp;Unregistered Sales of Equity Securities and Use of Proceeds**

**Unregistered Sales of Equity Securities and Use of Proceeds**

None.

**Purchases of Equity Securities by the Issuer and Affiliated Purchasers**

On September 4, 2024, we announced that our board of directors had authorized a new stock repurchase program for the period from August 29, 2024 until August 29, 2026, whereby we may repurchase shares of common stock not to exceed, in the aggregate, $200.0 million during the repurchase period.

During the three months ended April 30, 2025, we repurchased approximately 2,449,000 shares of our common stock during the period for a cost of $40.7 million under the new stock repurchase program and approximately 83,000 shares of common stock to facilitate income tax withholding or payments as described above for a cost $1.3 million, excluding an excise tax of $0.3 million.

From time to time, we have purchased shares of our common stock from our directors, officers, and other employees to facilitate income tax withholding or payments upon vesting of equity awards during Company-imposed trading blackout or lockup periods.

On August 16, 2022, the U.S. government enacted the Inflation Reduction Act (the "IRA") into law. The IRA imposes a 1% excise tax on share repurchases in excess of issuances, which is effective for us for repurchases completed after December 31, 2022. We reflect the excise tax within equity as part of the repurchase of the common stock.

Share repurchase activity during the three months ended April 30, 2025 was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total Number Shares Purchased** | **Average Price Paid per Share (1)** | **Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs** | **Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs<br>(in thousands)** |
| February 1, 2025 - February 28, 2025 |  | $— |  | $181317 |
| March 1, 2025 - March 31, 2025 |  |  |  | 181317 |
| April 1, 2025 - April 30, 2025 | 2532576 | 16.57 | 2449424 | 140641 |
|  | **2532576** | $**16.57** | **2449424** | $**140641** |

---

(1) Represents the approximate weighted-average price paid per share and excludes excise tax.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

The average price per share and aggregate cost amounts disclosed above do not include the cost of commissions or the excise tax.

**Item 3. Defaults Upon Senior Securities**

None.

**Item 4. Mine Safety Disclosures**

Not applicable.

**Item 5. Other Information**

During the three months ended April 30, 2025, no director or officer of the Company adopted, modified, or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each of these terms is defined in Item 408(a) of Regulation S-K.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

**Item 6. Exhibits**

The following exhibit list includes agreements that we entered into or that became effective during the three months ended April 30, 2025:

---

| | | |
|:---|:---|:---|
| **Number** | **Description** | **Filed Herewith /<br>Incorporated by<br>Reference from** |
| <u>[10.1](https://www.sec.gov/Archives/edgar/data/1166388/000119312525062690/d936282dex101.htm)</u> | <u>[Fifth Amendment, dated March 25, 2025, to the Credit Agreement, dated June 29, 2017, among Verint Systems Inc., as borrower, the lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent](https://www.sec.gov/Archives/edgar/data/1166388/000119312525062690/d936282dex101.htm)</u>\* | <u>[Form 8-K filed on March 25, 2025](https://www.sec.gov/Archives/edgar/data/1166388/000119312525062690/d936282dex101.htm)</u> |
| <u>[31.1](vrnt-ex311_20250430xform10.htm)</u> | <u>[Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](vrnt-ex311_20250430xform10.htm)</u> | <u>[Filed herewith](vrnt-ex311_20250430xform10.htm)</u> |
| <u>[31.2](vrnt-ex312_20250430xform10.htm)</u> | <u>[Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](vrnt-ex312_20250430xform10.htm)</u> | <u>[Filed herewith](vrnt-ex312_20250430xform10.htm)</u> |
| <u>[32.1](vrnt-ex321_20250430xform10.htm)</u> | <u>[Certification of Chief Executive Officer pursuant to Securities Exchange Act Rule 13a-14(b) and 18 U.S.C. Section 1350 (1)](vrnt-ex321_20250430xform10.htm)</u> | <u>[Filed herewith](vrnt-ex321_20250430xform10.htm)</u> |
| <u>[32.2](vrnt-ex322_20250430xform10.htm)</u> | <u>[Certification of Chief Financial Officer pursuant to Securities Exchange Act Rule 13a-14(b) and 18 U.S.C. Section 1350 (1)](vrnt-ex322_20250430xform10.htm)</u> | <u>[Filed herewith](vrnt-ex322_20250430xform10.htm)</u> |
| 101.INS | Inline XBRL Instance Document | Filed herewith |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | Filed herewith |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | Filed herewith |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | Filed herewith |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | Filed herewith |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | Filed herewith |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | Filed herewith |

---

(1)These exhibits are being "furnished" with this periodic report and are not deemed "filed" with the SEC and are not incorporated by reference in any filing of the company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

(\*)&nbsp;&nbsp;&nbsp;&nbsp;Certain exhibits and schedules have been omitted, and the Company agrees to furnish supplementally to the SEC a copy of any omitted exhibits or schedules upon request.

------

<u>[**Table of Contents**](#i8df5a199fd074a0db305e1acb96f1d88_10)</u>

**Signature**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
| | Verint Systems Inc. |
| June 4, 2025 | /s/ Grant Highlander |
| | Grant Highlander |
| | Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Dan Bodner, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Verint Systems Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | | |
|:---|:---|:---|:---|
| Dated: | June 4, 2025 | By: | /s/ Dan Bodner |
|  |  |  | Dan Bodner |
|  |  |  | Chief Executive Officer |
|  |  |  | Principal Executive Officer |

---

## Exhibit 31.2

**Exhibit 31.2**

CERTIFICATION BY THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Grant Highlander, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Verint Systems Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | | |
|:---|:---|:---|:---|
| Dated: | June 4, 2025 | By: | /s/ Grant Highlander |
|  |  |  | Grant Highlander |
|  |  |  | Chief Financial Officer |
|  |  |  | Principal Financial Officer |

---

## Exhibit 32.1

**Exhibit 32.1**

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Verint Systems Inc. (the "Company") on Form 10-Q for the period ended April 30, 2025 (the "Report"), I, Dan Bodner, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Dated: | June 4, 2025 | /s/ Dan Bodner |
| |  | Dan Bodner |
| |  | Chief Executive Officer |
| |  | Principal Executive Officer |

---

This certification accompanies this Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

## Exhibit 32.2

**Exhibit 32.2**

CERTIFICATION REQUIRED BY 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Verint Systems Inc. (the "Company") on Form 10-Q for the period ended April 30, 2025 (the "Report"), I, Grant Highlander, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Dated: | June 4, 2025 | /s/ Grant Highlander |
| |  | Grant Highlander |
| |  | Chief Financial Officer |
| |  | Principal Financial Officer |

---

This certification accompanies this Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

<br>